[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"_public_publisher_byId_16c4f885-6fe9-4e00-b613-f8a47530b62a":3,"_public_publication_all{\"sortAscending\":false,\"sortField\":\"updateTime\",\"page\":0,\"size\":10,\"facet\":true,\"searchKey\":\"publisherId:16c4f885-6fe9-4e00-b613-f8a47530b62a,\"}":100},{"code":4,"data":5,"meta":23},"SUCCESS",{"id":6,"createTime":7,"updateTime":8,"relativeEntities":9,"slug":10,"properties":11,"entityType":21,"verifyStatus":22,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":24,"subjectFields":25,"manageAffiliations":38,"indexDatabases":53,"url":89,"thumbnailPath":23,"statistic":90,"gsStatistic":23,"type":23,"analyzePriority":23},"16c4f885-6fe9-4e00-b613-f8a47530b62a","2023-05-29T10:28:23.090+00:00","2025-11-21T10:01:38.121+00:00",[],"Heart-Failure-Clinics",{"country":12,"eissn":14,"issn":16,"title":17,"introduce":19},{"VOID":13},"US",{"VOID":15},"15517136",{"VOID":15},{"EN":18},"Heart Failure Clinics",{"EN":20},"Heart failure is quickly becoming the most pressing health problem in the United States. Heart Failure Clinics provides practical, concise and easy-to-read coverage that encompasses everything you need to know about the current literature. Topics include acute decompensated heart failure, arrhythmias and sudden cardiac death, ventricular dysfunction, comorbidities of heart failure, diastolic dysfunction, genetic evaluation, ischemic heart disease, pulmonary arterial hypertension, and surgery\u002Ftransplantation.","PUBLISHER","PENDING",null,0,[26,32],{"id":27,"createTime":23,"updateTime":23,"relativeEntities":28,"label":29,"description":31,"parentId":23,"standard":23,"scholarHubFieldId":23},"2e748c70-3f53-41a9-99c9-1e3e45a3dc6d",[],{"EN":30},"Cardiology and Cardiovascular Medicine",{},{"id":33,"createTime":23,"updateTime":23,"relativeEntities":34,"label":35,"description":37,"parentId":23,"standard":23,"scholarHubFieldId":23},"0254e3e5-c28d-4a33-83da-81bc94d29ffd",[],{"EN":36},"Medicine (miscellaneous)",{},[39,46],{"id":40,"createTime":23,"updateTime":23,"relativeEntities":41,"slug":23,"properties":42,"entityType":23,"verifyStatus":23,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":23,"url":23,"parentIds":45,"statistic":23},"88620e1c-4e83-45c7-9895-c9773cdc5cb4",[],{"title":43},{"EN":44},"ELSEVIER SCIENCE INC",[],{"id":47,"createTime":23,"updateTime":23,"relativeEntities":48,"slug":23,"properties":49,"entityType":23,"verifyStatus":23,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":23,"url":23,"parentIds":52,"statistic":23},"18aff490-2422-46f1-a98d-c061dab6256d",[],{"title":50},{"EN":51},"Elsevier Inc.",[],[54,72],{"id":55,"indexDatabase":56,"url":66,"indexYears":67,"academicFieldIds":68,"indexDatabaseRanking":71},"fc8c1c5b-7854-4fd6-a09f-102301f3a21c",{"id":57,"createTime":23,"updateTime":23,"relativeEntities":58,"label":59,"description":61,"key":63,"publicationTags":64,"standard":23},"3c7051d4-eb7d-4c57-a56b-36fc74c5d1e9",[],{"EN":60,"VI":60},"Scopus - Elsevier",{"EN":60,"VI":62},"Cơ sở dữ liệu Scopus thuộc Elsevier","scopus",[65],"SCOPUS","https:\u002F\u002Fwww.scopus.com\u002Fsourceid\u002F4000148704","2005-2025",[69,70],"e89cebf4-fecf-4b74-8ab4-88fca891e4c2","d44e3b1d-4abe-47f2-b4aa-783c24a9f903","SCOPUS__Q2",{"id":73,"indexDatabase":74,"url":86,"indexYears":23,"academicFieldIds":87,"indexDatabaseRanking":23},"7cf346da-064a-45a5-8b6d-a9579dd58aec",{"id":75,"createTime":23,"updateTime":23,"relativeEntities":76,"label":77,"description":79,"key":82,"publicationTags":83,"standard":23},"a4921856-b128-4d9f-8f1f-e80813d3bbd4",[],{"EN":78,"VI":78},"ISI\u002FSCIE - Science Citation Index Expanded",{"EN":80,"VI":81},"SCIE database","Cơ sở dữ liệu SCIE","scie",[84,85],"SCIE","ISI","https:\u002F\u002Fmjl.clarivate.com\u002Fsearch-results?issn=1551-7136",[88],"22fd6c38-3ec0-41e0-8ae8-a4290171207e","https:\u002F\u002Fwww.journals.elsevier.com\u002Fheart-failure-clinics",{"impactFactor":24,"impactFactorByYear":91,"i10Index":24,"i10IndexLast5Year":24,"totalPublication":92,"totalPublicationByYear":93,"totalCitation":24,"totalCitationByYear":98,"totalCitationPerPublication":24,"totalCitationPerPublicationByYear":99,"hindexLast5Year":24,"hindex":24},{},150,{"2007":94,"2008":95,"2009":96,"2011":97},43,47,58,2,{},{},{"meta":101,"data":103},{"total":102},"78",[104,216,858,955,1054,1152,1221,1305,1402,1488],{"id":105,"createTime":106,"updateTime":107,"relativeEntities":108,"slug":109,"properties":110,"entityType":119,"verifyStatus":120,"verifyTime":121,"verifyNote":122,"languages":23,"translateLanguages":23,"viewCount":24,"primaryUrl":123,"fullTextUrl":23,"authors":124,"publicationType":157,"publisherRelationship":158,"citationCount":23,"citationInfo":23,"publishDate":211,"publishYear":212,"citationAnalyzeStatus":213,"lastCitationAnalyze":107,"indexDatabases":214,"openAccess":23,"references":23,"isForceReanalyzing":215},"635e59ca-e121-4707-80b0-3706fdcdde86","2024-01-17T09:01:34.621+00:00","2026-01-01T16:36:41.540+00:00",[],"Hemodynamic-Monitoring-in-Heart-Failure-A-Nursing-Perspective",{"title":111,"gsPaper":113,"references":115,"doi":117},{"EN":112},"Hemodynamic Monitoring in Heart Failure: A Nursing Perspective",{"VOID":114},"[]",{"VOID":116},"Cleland, 1999, Is the prognosis of heart failure improving?, Eur J Heart Fail, 1, 229, 10.1016\u002FS1388-9842(99)00032-X\nThe Adhere Scientific Advisory Committee\nFonarow, 2007, Influence of a performance-improvement initiative on quality of care for patients hospitalized with heart failure: results of the organized program to initiate lifesaving treatment in hospitalized patients with heart failure (OPTIMIZE-HF), Arch Intern Med, 167, 1493, 10.1001\u002Farchinte.167.14.1493\nHobbs, 2000, European survey of primary care physician perceptions on heart failure diagnosis and management (Euro-HF), Eur Heart J, 21, 1877, 10.1053\u002Feuhj.2000.2170\nFriedman, 2001, Relationship of physical symptoms and physical functioning to depression in patients with heart failure, Heart Lung, 30, 98, 10.1067\u002Fmhl.2001.114180\nAdamson, 2003, Ongoing right ventricular hemodynamics in heart failure: clinical value of measurements derived from an implantable monitoring system, J Am Coll Cardiol, 41, 565, 10.1016\u002FS0735-1097(02)02896-6\nFonarow, 2003, The Acute Decompensated Heart Failure Registry (ADHERE): opportunities to improve care of patients hospitalized with acute decompensated heart failure, Rev Cardiovasc Med, 4, S21\nTrupp, 2007, Disease management overview, 241\nFaxon, 2003, Improving quality of care through disease management: principles and recommendations from the American Heart Association's Expert Panel on Disease Management, Circulation, 109, 2651, 10.1161\u002F01.CIR.0000128373.90851.7B\nWhellan, 2005, Metaanalysis and review of heart failure disease management randomized controlled clinical studies, Am Heart J, 149, 722, 10.1016\u002Fj.ahj.2004.09.023\nHunt, 2005, ACC\u002FAHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult–summary article, Circulation, 112, 1825, 10.1161\u002FCIRCULATIONAHA.105.167587\nAbraham, 2002, Cardiac resynchronization in chronic heart failure, N Engl J Med, 346, 1845, 10.1056\u002FNEJMoa013168\nBristow, 2004, Cardiac resynchronization therapy with or without implantable defibrillator in advanced heart failure, N Engl J Med, 350, 2140, 10.1056\u002FNEJMoa032423\nMoss, 2002, Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction, N Engl J Med, 346, 877, 10.1056\u002FNEJMoa013474\nFriedman, 1997, Older adults' symptoms and their duration before hospitalization for heart failure, Heart Lung, 26, 169, 10.1016\u002FS0147-9563(97)90053-4\nVinson, 1990, Early readmission of elderly patients with congestive heart failure, J Am Geriatr Soc, 38, 1290, 10.1111\u002Fj.1532-5415.1990.tb03450.x\nCarlson, 2001, Self-care abilities of patients with heart failure, Heart Lung, 30, 351, 10.1067\u002Fmhl.2001.118611\nRoccaforte, 2005, Effectiveness of comprehensive disease management programmes in improving clinical outcomes in heart failure patients. A meta-analysis, Eur J Heart Fail, 7, 1133, 10.1016\u002Fj.ejheart.2005.08.005\nDao, 2001, Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent care setting, J Am Coll Cardiol, 37, 379, 10.1016\u002FS0735-1097(00)01156-6\nStevenson, 1989, The limited reliability of physical signs for estimating hemodynamics in chronic heart failure, JAMA, 261, 884, 10.1001\u002Fjama.1989.03420060100040\nAdamson, 2003, Relationship between right ventricular pressures variability and heart failure related adverse events, J Am Coll Cardiol, 41, 10.1016\u002FS0735-1097(03)80250-4\nClark\nBondmass\nGoldberg, 2003, Randomized trial of a daily electronic home monitoring system in patients with advanced heart failure: the Weight Monitoring in Heart Failure (WHARF) trial, Am Heart J, 146, 705, 10.1016\u002FS0002-8703(03)00393-4\nLouis, 2003, A systematic review of telemonitoring for the management of heart failure, The Eur J Heart Fail, 5, 583, 10.1016\u002FS1388-9842(03)00160-0\nRathman, 2008, Using devices for physiologic monitoring in heart failure, Journal of Cardiovascular Nursing, 23, 159, 10.1097\u002F01.JCN.0000305077.28528.92\nYu, 2005, Intrathoracic impedance monitoring in patients with heart failure, Circulation, 112, 841, 10.1161\u002FCIRCULATIONAHA.104.492207\nAbraham, 2005, Fluid Accumulation Status Trial (FAST), Heart Rhythm, 2, S65\nRathman, 2006, Monitoring intrathoracic impedance with CRT-D devices: insight into volume status, Prog Cardiovasc Nurs, 21, 97, 10.1111\u002Fj.0889-7204.2006.05319.x\nSaxon, 2007, Remote active monitoring in patients with heart failure (RAPID-HF): design and rationale, J Card Fail, 13, 241, 10.1016\u002Fj.cardfail.2006.12.004\nBourge RC, Abraham WT, Aaron M, et al. Preliminary results of the COMPASS-HF Trial. Presented at a late-breaking clinical trials session at the 78th Annual Scientific Sessions of the American Heart Association. Dallas (TX), November 13–16, 2005.\nKadhiresan, 2004, The role of implantable sensors for management of heart failure, Stud Health Technol Inform, 108, 219\nStevenson, 2006, Are hemodynamic goals viable in tailoring heart failure therapy? Hemodynamic goals are relevant. Controversies in cardiovascular medicine, Circulation, 113, 1020, 10.1161\u002FCIRCULATIONAHA.104.478321\nWadas, 2005, The implantable hemodynamic monitoring system, Crit Care Nurse, 25, 14, 10.4037\u002Fccn2005.25.5.14\nMagalski, 2002, Continuous ambulatory right heart pressure measurements with an implantable hemodynamic monitor: a multicenter 12-month follow-up study of patients with chronic heart failure, J Card Fail, 8, 63, 10.1054\u002Fjcaf.2002.32373\nAdamson, 2007, Reducing events in patients with chronic heart failure (REDUCEhf) study design: continuous hemodynamic monitoring with an implantable defibrillator, Clin Cardiol, 30, 567, 10.1002\u002Fclc.20250\nOhlsson, 2001, Continuous ambulatory monitoring of absolute right ventricular pressure and mixed venous oxygen saturation in patients with heart failure using an implantable hemodynamic monitor, Eur Heart J, 22, 942, 10.1053\u002Feuhj.2000.2419\nWalton, 2005, The HeartPOD implantable heart failure therapy system, Heart Lung Circ, 14S, S31, 10.1016\u002Fj.hlc.2005.09.003\nTang, 2007, Collaboration among general cardiologists, heart failure specialists, and electrophysiologists: what are the barriers?, Am J Cardiol, 99, 41G, 10.1016\u002Fj.amjcard.2007.02.044\nAdvaMed",{"VOID":118},"10.1016\u002Fj.hfc.2008.11.006","PUBLICATION","VERIFIED","2024-05-08T23:30:59.947+00:00","Auto Verify","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS155171360800158X",[125,141],{"id":126,"sortIndex":24,"researcher":23,"roles":127,"affiliations":129,"properties":138},"e1cb59e9-5784-4d2f-922d-cce4f69e88c2",[128],"AUTHOR",[130],{"id":131,"sortIndex":24,"affiliation":132,"properties":23},"25a333aa-82a1-4245-81df-214be8c84f14",{"id":131,"createTime":23,"updateTime":23,"relativeEntities":133,"slug":23,"properties":134,"entityType":23,"verifyStatus":23,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":23,"url":23,"parentIds":137,"statistic":23},[],{"title":135},{"VI":136},"St. Luke's Episcopal Institute–Texas Heart Institute, Houston, TX, USA",[],{"title":139},{"VI":140},"Erin K. Donaho",{"id":142,"sortIndex":143,"researcher":23,"roles":144,"affiliations":145,"properties":154},"85114ac7-a569-45fe-8872-276a1c5458aa",1,[128],[146],{"id":147,"sortIndex":24,"affiliation":148,"properties":23},"c0a48dd2-19ab-4137-bb97-9e361ff38848",{"id":147,"createTime":23,"updateTime":23,"relativeEntities":149,"slug":23,"properties":150,"entityType":23,"verifyStatus":23,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":23,"url":23,"parentIds":153,"statistic":23},[],{"title":151},{"VI":152},"The Ohio State University, College of Nursing, Columbus, OH, USA",[],{"title":155},{"VI":156},"Robin J. Trupp","ARTICLE",{"url":123,"publisher":159,"properties":206},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":160,"slug":10,"properties":161,"entityType":21,"verifyStatus":22,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":24,"subjectFields":166,"manageAffiliations":175,"indexDatabases":186,"url":89,"thumbnailPath":23,"statistic":201,"gsStatistic":23,"type":23,"analyzePriority":23},[],{"country":162,"eissn":163,"issn":164,"title":165},{"VOID":13},{"VOID":15},{"VOID":15},{"EN":18},[167,171],{"id":27,"createTime":23,"updateTime":23,"relativeEntities":168,"label":169,"description":170,"parentId":23,"standard":23,"scholarHubFieldId":23},[],{"EN":30},{},{"id":33,"createTime":23,"updateTime":23,"relativeEntities":172,"label":173,"description":174,"parentId":23,"standard":23,"scholarHubFieldId":23},[],{"EN":36},{},[176,181],{"id":40,"createTime":23,"updateTime":23,"relativeEntities":177,"slug":23,"properties":178,"entityType":23,"verifyStatus":23,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":23,"url":23,"parentIds":180,"statistic":23},[],{"title":179},{"EN":44},[],{"id":47,"createTime":23,"updateTime":23,"relativeEntities":182,"slug":23,"properties":183,"entityType":23,"verifyStatus":23,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":23,"url":23,"parentIds":185,"statistic":23},[],{"title":184},{"EN":51},[],[187,194],{"id":55,"indexDatabase":188,"url":66,"indexYears":67,"academicFieldIds":193,"indexDatabaseRanking":71},{"id":57,"createTime":23,"updateTime":23,"relativeEntities":189,"label":190,"description":191,"key":63,"publicationTags":192,"standard":23},[],{"EN":60,"VI":60},{"EN":60,"VI":62},[65],[69,70],{"id":73,"indexDatabase":195,"url":86,"indexYears":23,"academicFieldIds":200,"indexDatabaseRanking":23},{"id":75,"createTime":23,"updateTime":23,"relativeEntities":196,"label":197,"description":198,"key":82,"publicationTags":199,"standard":23},[],{"EN":78,"VI":78},{"EN":80,"VI":81},[84,85],[88],{"impactFactor":24,"impactFactorByYear":202,"i10Index":24,"i10IndexLast5Year":24,"totalPublication":92,"totalPublicationByYear":203,"totalCitation":24,"totalCitationByYear":204,"totalCitationPerPublication":24,"totalCitationPerPublicationByYear":205,"hindexLast5Year":24,"hindex":24},{},{"2007":94,"2008":95,"2009":96,"2011":97},{},{},{"pages":207,"volume":209},{"VOID":208},"271-278",{"VOID":210},"5","2009-04-01",2009,"ERROR_IN_GET_PLATFORM_ID",[71,84],false,{"id":217,"createTime":218,"updateTime":219,"relativeEntities":220,"slug":221,"properties":222,"entityType":119,"verifyStatus":120,"verifyTime":229,"verifyNote":122,"languages":23,"translateLanguages":23,"viewCount":24,"primaryUrl":230,"fullTextUrl":23,"authors":231,"publicationType":157,"publisherRelationship":266,"citationCount":24,"citationInfo":319,"publishDate":322,"publishYear":320,"citationAnalyzeStatus":22,"lastCitationAnalyze":323,"indexDatabases":324,"openAccess":23,"references":325,"isForceReanalyzing":215},"720425ee-999d-41fc-803e-2993cfb1e888","2024-01-21T07:44:11.674+00:00","2025-07-31T08:56:00.764+00:00",[],"Role-of-Echocardiography-in-the-Diagnostic-Assessment-and-Etiology-of-Heart-Failure-in-the-Elderly-Opacify-Quantify-and-Rectify",{"title":223,"gsPaper":225,"doi":227},{"EN":224},"Role of Echocardiography in the Diagnostic Assessment and Etiology of Heart Failure in the Elderly—Opacify, Quantify, and Rectify",{"VOID":226},"[\"17202930288671016336\"]",{"VOID":228},"10.1016\u002Fj.hfc.2007.07.006","2024-05-01T12:06:00.824+00:00","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1551713607001031",[232,249],{"id":233,"sortIndex":24,"researcher":23,"roles":234,"affiliations":235,"properties":244},"acbe8d34-7027-4d9a-81de-b3e3edbac166",[128],[236],{"id":237,"sortIndex":24,"affiliation":238,"properties":23},"7f5f52b0-fb51-4b15-9875-5507e95c44f2",{"id":237,"createTime":23,"updateTime":23,"relativeEntities":239,"slug":23,"properties":240,"entityType":23,"verifyStatus":23,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":23,"url":23,"parentIds":243,"statistic":23},[],{"title":241},{"VI":242},"University of Arizona, Sarver Heart Center, Tucson, AZ, USA",[],{"title":245,"gsAuthor":247},{"VI":246},"Vincent L. Sorrell",{"VOID":248},"[\"ooe8k7gAAAAJ\"]",{"id":250,"sortIndex":143,"researcher":23,"roles":251,"affiliations":252,"properties":261},"97dad345-b083-43b6-b27a-8e6088d22bf1",[128],[253],{"id":254,"sortIndex":24,"affiliation":255,"properties":23},"a4b7b9ca-0471-41a1-a1e9-59f97b815d2e",{"id":254,"createTime":23,"updateTime":23,"relativeEntities":256,"slug":23,"properties":257,"entityType":23,"verifyStatus":23,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":23,"url":23,"parentIds":260,"statistic":23},[],{"title":258},{"EN":259},"University of Alabama at Birmingham, Birmingham, AL, USA;",[],{"title":262,"gsAuthor":264},{"VI":263},"Navin C. Nanda",{"VOID":265},"[\"VGZS-KQAAAAJ\"]",{"url":230,"publisher":267,"properties":314},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":268,"slug":10,"properties":269,"entityType":21,"verifyStatus":22,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":24,"subjectFields":274,"manageAffiliations":283,"indexDatabases":294,"url":89,"thumbnailPath":23,"statistic":309,"gsStatistic":23,"type":23,"analyzePriority":23},[],{"country":270,"eissn":271,"issn":272,"title":273},{"VOID":13},{"VOID":15},{"VOID":15},{"EN":18},[275,279],{"id":27,"createTime":23,"updateTime":23,"relativeEntities":276,"label":277,"description":278,"parentId":23,"standard":23,"scholarHubFieldId":23},[],{"EN":30},{},{"id":33,"createTime":23,"updateTime":23,"relativeEntities":280,"label":281,"description":282,"parentId":23,"standard":23,"scholarHubFieldId":23},[],{"EN":36},{},[284,289],{"id":40,"createTime":23,"updateTime":23,"relativeEntities":285,"slug":23,"properties":286,"entityType":23,"verifyStatus":23,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":23,"url":23,"parentIds":288,"statistic":23},[],{"title":287},{"EN":44},[],{"id":47,"createTime":23,"updateTime":23,"relativeEntities":290,"slug":23,"properties":291,"entityType":23,"verifyStatus":23,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":23,"url":23,"parentIds":293,"statistic":23},[],{"title":292},{"EN":51},[],[295,302],{"id":55,"indexDatabase":296,"url":66,"indexYears":67,"academicFieldIds":301,"indexDatabaseRanking":71},{"id":57,"createTime":23,"updateTime":23,"relativeEntities":297,"label":298,"description":299,"key":63,"publicationTags":300,"standard":23},[],{"EN":60,"VI":60},{"EN":60,"VI":62},[65],[69,70],{"id":73,"indexDatabase":303,"url":86,"indexYears":23,"academicFieldIds":308,"indexDatabaseRanking":23},{"id":75,"createTime":23,"updateTime":23,"relativeEntities":304,"label":305,"description":306,"key":82,"publicationTags":307,"standard":23},[],{"EN":78,"VI":78},{"EN":80,"VI":81},[84,85],[88],{"impactFactor":24,"impactFactorByYear":310,"i10Index":24,"i10IndexLast5Year":24,"totalPublication":92,"totalPublicationByYear":311,"totalCitation":24,"totalCitationByYear":312,"totalCitationPerPublication":24,"totalCitationPerPublicationByYear":313,"hindexLast5Year":24,"hindex":24},{},{"2007":94,"2008":95,"2009":96,"2011":97},{},{},{"pages":315,"volume":317},{"VOID":316},"403-422",{"VOID":318},"3",{"total":24,"publishYear":320,"statisticByYear":321},2007,{},"2007-10-01","2025-07-31T08:56:00.763+00:00",[71,84],[326,335,339,348,354,358,363,371,379,384,392,395,399,407,413,421,427,431,439,447,455,463,469,477,481,485,493,498,506,511,519,525,531,539,547,555,563,566,574,578,586,591,599,602,610,619,627,635,643,652,660,668,675,680,688,694,702,706,711,717,720,724,732,740,746,754,759,764,772,776,784,790,798,805,813,821,827,833,836,844,850],{"id":23,"text":327,"url":328,"identifiers":329},"Kannel, 1991, Epidemiology of heart failure, Am Heart J, 121, 951, 10.1016\u002F0002-8703(91)90225-7","https:\u002F\u002Fdoi.org\u002F10.1161\u002Fcircresaha.113.300268",{"mag":330,"pmc":331,"openalex":332,"pm":333,"doi":334},"2168048360","3806290","W2168048360","23989710","10.1161\u002Fcircresaha.113.300268",{"id":23,"text":336,"url":23,"identifiers":337},"Bonow, 1992, Left ventricular diastolic dysfunction as a cause of congestive heart failure: mechanisms and management, Ann Intern Med, 117, 502, 10.7326\u002F0003-4819-117-6-502",{"doi":338},"10.7326\u002F0003-4819-117-6-502",{"id":23,"text":340,"url":341,"identifiers":342},"Ihlen, 1984, Determination of cardiac output by Doppler echocardiography, Br Heart J, 51, 54, 10.1136\u002Fhrt.51.1.54","https:\u002F\u002Fdoi.org\u002F10.1136\u002Fhrt.51.1.54",{"mag":343,"pmc":344,"openalex":345,"pm":346,"doi":347},"2006860851","482313","W2006860851","6689921","10.1136\u002Fhrt.51.1.54",{"id":349,"text":350,"url":351,"identifiers":352},"848a2920-48ab-4262-a2c9-2d3142197715","Ghali, 1992, Bedside diagnosis of preserved versus impaired left ventricular systolic function in heart failure, Am J Cardiol, 67, 1002, 10.1016\u002F0002-9149(91)90174-J","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002F000291499190174J",{"doi":353},"10.1016\u002F0002-9149(91)90174-j",{"id":23,"text":355,"url":23,"identifiers":356},"Sorrell, 2000, Role of echocardiography in the diagnosis and management of heart failure in the elderly, Clin Geriatr Med, 16, 457, 10.1016\u002FS0749-0690(05)70023-9",{"doi":357},"10.1016\u002FS0749-0690(05)70023-9",{"id":23,"text":359,"url":360,"identifiers":361},"Parisi, 1979, Approaches to determination of left ventricular volumes and ejection fraction by real-time two-dimensional echocardiography, Clin Cardiol, 2, 257, 10.1002\u002Fclc.4960020404","http:\u002F\u002Fdx.doi.org\u002F10.1002\u002Fclc.4960020404",{"doi":362},"10.1002\u002Fclc.4960020404",{"id":23,"text":364,"url":365,"identifiers":366},"Caidahl, 1998, New concept in echocardiography: harmonic imaging of tissue without use of a contrast agent, Lancet, 352, 1264, 10.1016\u002FS0140-6736(98)02361-7","https:\u002F\u002Fdoi.org\u002F10.1016\u002Fs0140-6736(98)02361-7",{"mag":367,"openalex":368,"pm":369,"doi":370},"2139933538","W2139933538","9788456","10.1016\u002Fs0140-6736(98)02361-7",{"id":23,"text":372,"url":373,"identifiers":374},"Senior, 1999, Role of contrast echocardiography for the assessment of left ventricular function, Echocardiogr, 16, 747, 10.1111\u002Fj.1540-8175.1999.tb00145.x","https:\u002F\u002Fdoi.org\u002F10.1111\u002Fj.1540-8175.1999.tb00145.x",{"mag":375,"openalex":376,"pm":377,"doi":378},"2010279355","W2010279355","11175218","10.1111\u002Fj.1540-8175.1999.tb00145.x",{"id":23,"text":380,"url":381,"identifiers":382},"Vandenberg, 1992, Estimation of left ventricular cavity area with an on-line, semi-automated echocardiographic edge detection system, Circulation, 86, 159, 10.1161\u002F01.CIR.86.1.159","http:\u002F\u002Fdx.doi.org\u002F10.1016\u002F0735-1097(91)92130-e",{"doi":383},"10.1016\u002F0735-1097(91)92130-e",{"id":23,"text":385,"url":386,"identifiers":387},"Corsi, 2005, Volumetric quantification of global and regional left ventricular function from real-time three-dimensional echocardiographic images, Circulation, 112, 1161, 10.1161\u002FCIRCULATIONAHA.104.513689","https:\u002F\u002Fdoi.org\u002F10.1161\u002Fcirculationaha.104.513689",{"mag":388,"openalex":389,"pm":390,"doi":391},"2092081754","W2092081754","16103242","10.1161\u002Fcirculationaha.104.513689",{"id":23,"text":393,"url":23,"identifiers":394},"1991, 377",{},{"id":23,"text":396,"url":23,"identifiers":397},"Richardson, 1996, Report of the 1995 World Health Organization\u002FInternational Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies, Circulation, 93, 841, 10.1161\u002F01.CIR.93.5.841",{"doi":398},"10.1161\u002F01.CIR.93.5.841",{"id":23,"text":400,"url":401,"identifiers":402},"Simonson, 1989, Descent of the base of the left ventricle: an echocardiographic index of left ventricular function, J Am Soc Echocardiogr, 2, 25, 10.1016\u002FS0894-7317(89)80026-4","https:\u002F\u002Fdoi.org\u002F10.1016\u002Fs0894-7317(89)80026-4",{"mag":403,"openalex":404,"pm":405,"doi":406},"1983003774","W1983003774","2534047","10.1016\u002Fs0894-7317(89)80026-4",{"id":408,"text":409,"url":410,"identifiers":411},"8481ecf8-55e6-44c0-bad1-835267e6bc80","Vandenbossche, 1988, Relation of left ventricular shape to volume and mass in patients with minimally symptomatic chronic aortic regurgitation, Am Heart J, 116, 1022, 10.1016\u002F0002-8703(88)90154-8","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002F0002870388901548",{"doi":412},"10.1016\u002F0002-8703(88)90154-8",{"id":23,"text":414,"url":415,"identifiers":416},"Gorcsan, 1994, Rapid estimation of left ventricular contractility from end-systolic relations by echocardiographic automated border detection and femoral arterial pressure, Anesthesiology, 81, 553, 10.1097\u002F00000542-199409000-00006","https:\u002F\u002Fdoi.org\u002F10.1097\u002F00000542-199409000-00006",{"mag":417,"openalex":418,"pm":419,"doi":420},"1985195797","W1985195797","8092499","10.1097\u002F00000542-199409000-00006",{"id":422,"text":423,"url":424,"identifiers":425},"522822d3-2f27-4d23-96d2-9ee7d16a9162","Yoerger, 2005, J Am Coll Cardiol, 45, 860, 10.1016\u002Fj.jacc.2004.10.070","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0735109704024878",{"doi":426},"10.1016\u002Fj.jacc.2004.10.070",{"id":23,"text":428,"url":23,"identifiers":429},"Cerqueira, 2002, Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association, Circulation, 105, 539, 10.1161\u002Fhc0402.102975",{"doi":430},"10.1161\u002Fhc0402.102975",{"id":23,"text":432,"url":433,"identifiers":434},"Acquatella, 1988, Echocardiographic recognition of Chagas' disease and endomyocardial fibrosis, J Am Soc Echocardiogr, 1, 60, 10.1016\u002FS0894-7317(88)80064-6","https:\u002F\u002Fdoi.org\u002F10.1016\u002Fs0894-7317(88)80064-6",{"mag":435,"openalex":436,"pm":437,"doi":438},"1967879941","W1967879941","3078542","10.1016\u002Fs0894-7317(88)80064-6",{"id":23,"text":440,"url":441,"identifiers":442},"Bodiwala, 2005, Live three-dimensional transthoracic echocardiographic assessment of ventricular noncompaction, Echocardiogr, 22, 611, 10.1111\u002Fj.1540-8175.2005.40106.x","https:\u002F\u002Fdoi.org\u002F10.1111\u002Fj.1540-8175.2005.40106.x",{"mag":443,"openalex":444,"pm":445,"doi":446},"1926531437","W1926531437","16060900","10.1111\u002Fj.1540-8175.2005.40106.x",{"id":23,"text":448,"url":449,"identifiers":450},"Nanda, 1974, Echocardiographic evaluation of pulmonary hypertension, Circulation, 50, 575, 10.1161\u002F01.CIR.50.3.575","https:\u002F\u002Fdoi.org\u002F10.1161\u002F01.cir.50.3.575",{"mag":451,"openalex":452,"pm":453,"doi":454},"2079825747","W2079825747","4412894","10.1161\u002F01.cir.50.3.575",{"id":23,"text":456,"url":457,"identifiers":458},"McConnell, 1996, Regional right ventricular dysfunction detected by echocardiography in acute pulmonary embolism, Am J Cardiol, 78, 469, 10.1016\u002FS0002-9149(96)00339-6","https:\u002F\u002Fdoi.org\u002F10.1016\u002Fs0002-9149(96)00339-6",{"mag":459,"openalex":460,"pm":461,"doi":462},"2006290430","W2006290430","8752195","10.1016\u002Fs0002-9149(96)00339-6",{"id":464,"text":465,"url":466,"identifiers":467},"4c68646b-0035-4279-8000-0006b275d4fa","Kotler, 1981, Bedside diagnosis of organic murmurs in the elderly, Geriatrics, 36, 107","https:\u002F\u002Flink.springer.com\u002F10.1007\u002Fs10440-022-00541-7",{"doi":468},"10.1007\u002Fs10440-022-00541-7",{"id":23,"text":470,"url":471,"identifiers":472},"Fan, 1998, Color-guided Doppler echocardiographic assessment in assessment of aortic valve stenosis, J Am Coll Cardiol, 12, 441, 10.1016\u002F0735-1097(88)90417-2","https:\u002F\u002Fdoi.org\u002F10.1016\u002F0735-1097(88)90417-2",{"mag":473,"openalex":474,"pm":475,"doi":476},"2054773929","W2054773929","3392337","10.1016\u002F0735-1097(88)90417-2",{"id":23,"text":478,"url":23,"identifiers":479},"Naqvi, 1999, Aortic stenosis: the role of transesophageal echocardiography, Echocardiogr, 16, 677, 10.1111\u002Fj.1540-8175.1999.tb00125.x",{"doi":480},"10.1111\u002Fj.1540-8175.1999.tb00125.x",{"id":23,"text":482,"url":23,"identifiers":483},"Bermejo, 1999, Stress echocardiography in aortic stenosis: insights into valve mechanics and hemodynamics, Echocardiogr, 16, 689, 10.1111\u002Fj.1540-8175.1999.tb00126.x",{"doi":484},"10.1111\u002Fj.1540-8175.1999.tb00126.x",{"id":23,"text":486,"url":487,"identifiers":488},"Vengala, 2004, Usefulness of live three-dimensional transthoracic echocardiography in aortic valve stenosis evaluation, Am J Geriatr Cardiol, 13, 279, 10.1111\u002Fj.1076-7460.2004.02710.x","https:\u002F\u002Fdoi.org\u002F10.1111\u002Fj.1076-7460.2004.02710.x",{"mag":489,"openalex":490,"pm":491,"doi":492},"2060608453","W2060608453","15365294","10.1111\u002Fj.1076-7460.2004.02710.x",{"id":23,"text":494,"url":495,"identifiers":496},"Bargiggia, 1991, A new method for quantitation of mitral regurgitation based on color flow Doppler imaging of flow convergence proximal to regurgitant oriface, Circulation, 84, 1481, 10.1161\u002F01.CIR.84.4.1481","http:\u002F\u002Fdx.doi.org\u002F10.1161\u002F01.cir.84.4.1481",{"doi":497},"10.1161\u002F01.cir.84.4.1481",{"id":23,"text":499,"url":500,"identifiers":501},"Khanna, 2004, Quantification of mitral regurgitation by live three-dimensional transthoracic echocardiographic measurements of vena contracta area, Echocardiography, 21, 737, 10.1111\u002Fj.0742-2822.2004.40027.x","https:\u002F\u002Fdoi.org\u002F10.1111\u002Fj.0742-2822.2004.40027.x",{"mag":502,"openalex":503,"pm":504,"doi":505},"3196074034","W3196074034","15546375","10.1111\u002Fj.0742-2822.2004.40027.x",{"id":23,"text":507,"url":508,"identifiers":509},"Khanna, 2005, Transthoracic and transesophageal echocardiographic assessment of mitral regurgitation severity: usefulness of qualitative and semi-quantitative techniques, Echocardiography, 22, 748, 10.1111\u002Fj.1540-8175.2005.00170.x","http:\u002F\u002Fdx.doi.org\u002F10.1111\u002Fj.1540-8175.2005.00170.x",{"doi":510},"10.1111\u002Fj.1540-8175.2005.00170.x",{"id":23,"text":512,"url":513,"identifiers":514},"Ling, 1996, Clinical outcome of mitral regurgitation due to flail leaflet, N Engl J Med, 335, 1417, 10.1056\u002FNEJM199611073351902","https:\u002F\u002Fdoi.org\u002F10.1056\u002Fnejm199611073351902",{"mag":515,"openalex":516,"pm":517,"doi":518},"1997162840","W1997162840","8875918","10.1056\u002Fnejm199611073351902",{"id":520,"text":521,"url":522,"identifiers":523},"d26e81b2-ab71-425c-80c6-d2f3acffc468","Ghio, 2000, Prognostic usefulness of the tricuspid annular plane systolic excursion in patients with congestive heart failure secondary to idiopathic or ischemic dilated cardiomyopathy, Am J Cardiol, 85, 837, 10.1016\u002FS0002-9149(99)00877-2","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0002914999008772",{"doi":524},"10.1016\u002Fs0002-9149(99)00877-2",{"id":526,"text":527,"url":528,"identifiers":529},"e77707b8-d874-4279-b38a-f855c2a5dc95","Bleeker, 2005, Comparison of effectiveness of cardiac resynchronization therapy in patients \u003C70 versus >\u002F= 70 years of age, Am J Cardiol, 96, 420, 10.1016\u002Fj.amjcard.2005.03.091","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0002914905007472",{"doi":530},"10.1016\u002Fj.amjcard.2005.03.091",{"id":23,"text":532,"url":533,"identifiers":534},"Suffoletto, 2006, Novel speckle-tracking radial strain from routine black-and-white echocardiographic images to quantify dyssynchrony and predict response to cardiac resynchronization therapy, Circulation, 113, 960, 10.1161\u002FCIRCULATIONAHA.105.571455","https:\u002F\u002Fdoi.org\u002F10.1161\u002Fcirculationaha.105.571455",{"mag":535,"openalex":536,"pm":537,"doi":538},"2079861388","W2079861388","16476850","10.1161\u002Fcirculationaha.105.571455",{"id":23,"text":540,"url":541,"identifiers":542},"Cahill, 2006, Progression of preserved systolic function heart failure to systolic dysfunction—a natural history study, Int J Cardiol, 106, 95, 10.1016\u002Fj.ijcard.2004.12.096","https:\u002F\u002Fdoi.org\u002F10.1016\u002Fj.ijcard.2004.12.096",{"mag":543,"openalex":544,"pm":545,"doi":546},"2072998821","W2072998821","16321672","10.1016\u002Fj.ijcard.2004.12.096",{"id":23,"text":548,"url":549,"identifiers":550},"Iriarte, 1993, Congestive heart failure from left ventricular diastolic dysfunction in systemic hypertension, Am J Cardiol, 71, 308, 10.1016\u002F0002-9149(93)90796-F","https:\u002F\u002Fdoi.org\u002F10.1016\u002F0002-9149(93)90796-f",{"mag":551,"openalex":552,"pm":553,"doi":554},"1990563332","W1990563332","8427173","10.1016\u002F0002-9149(93)90796-f",{"id":23,"text":556,"url":557,"identifiers":558},"Gola, 1996, Comparison of Doppler echocardiography with thermodilution for assessing cardiac output in advanced congestive heart failure, Am J Cardiol, 78, 708, 10.1016\u002FS0002-9149(96)00406-7","https:\u002F\u002Fdoi.org\u002F10.1016\u002Fs0002-9149(96)00406-7",{"mag":559,"openalex":560,"pm":561,"doi":562},"2167952504","W2167952504","8831417","10.1016\u002Fs0002-9149(96)00406-7",{"id":464,"text":564,"url":466,"identifiers":565},"Tei, 1995, New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function—a study in normals and dilated cardiomyopathy, J Cardiol, 26, 357",{"doi":468},{"id":23,"text":567,"url":568,"identifiers":569},"Tei, 1996, Doppler echocardiographic index for assessment of global right ventricular function, J Am Soc Echocardiogr, 9, 838, 10.1016\u002FS0894-7317(96)90476-9","https:\u002F\u002Fdoi.org\u002F10.1016\u002Fs0894-7317(96)90476-9",{"mag":570,"openalex":571,"pm":572,"doi":573},"2001674341","W2001674341","8943444","10.1016\u002Fs0894-7317(96)90476-9",{"id":23,"text":575,"url":23,"identifiers":576},"Zile, 2001, Heart failure with a normal ejection fraction: is measurement of diastolic function necessary to make the diagnosis of diastolic heart failure?, Circulation, 104, 779, 10.1161\u002Fhc3201.094226",{"doi":577},"10.1161\u002Fhc3201.094226",{"id":23,"text":579,"url":580,"identifiers":581},"Thomas, 1991, Echocardiographic Doppler evaluation of left ventricular diastolic function: physics and physiology, Circulation, 84, 977, 10.1161\u002F01.CIR.84.3.977","https:\u002F\u002Fdoi.org\u002F10.1161\u002F01.cir.84.3.977",{"mag":582,"openalex":583,"pm":584,"doi":585},"2057691648","W2057691648","1884473","10.1161\u002F01.cir.84.3.977",{"id":23,"text":587,"url":588,"identifiers":589},"Nishimura, 1997, Evaluation of diastolic filling of the left ventricle in health and disease: Doppler echocardiography is the clinician's Rosetta Stone, J Am Coll Cardiol, 30, 8, 10.1016\u002FS0735-1097(97)00144-7","http:\u002F\u002Fdx.doi.org\u002F10.1016\u002Fs0735-1097(97)00144-7",{"doi":590},"10.1016\u002Fs0735-1097(97)00144-7",{"id":23,"text":592,"url":593,"identifiers":594},"Pinamonti, 1997, Persistence of restrictive left ventricular filling pattern in dilated cardiomyopathy: an ominous prognostic sign, J Am Coll Cardiol, 29, 604, 10.1016\u002FS0735-1097(96)00539-6","https:\u002F\u002Fdoi.org\u002F10.1016\u002Fs0735-1097(96)00539-6",{"mag":595,"openalex":596,"pm":597,"doi":598},"2025938094","W2025938094","9060900","10.1016\u002Fs0735-1097(96)00539-6",{"id":23,"text":600,"url":23,"identifiers":601},"Oh, 1999",{},{"id":23,"text":603,"url":604,"identifiers":605},"Dumesnil, 1991, Use of Valsalva maneuver to unmask left ventricular diastolic function abnormalities by Doppler echocardiography in patients with coronary artery disease or systemic hypertension, Am J Cardiol, 68, 515, 10.1016\u002F0002-9149(91)90788-M","https:\u002F\u002Fdoi.org\u002F10.1016\u002F0002-9149(91)90788-m",{"mag":606,"openalex":607,"pm":608,"doi":609},"2003387215","W2003387215","1872280","10.1016\u002F0002-9149(91)90788-m",{"id":23,"text":611,"url":612,"identifiers":613},"Marwick, 2003, Clinical applications of tissue Doppler imaging: a promise fulfilled, Heart, 89, 1377, 10.1136\u002Fheart.89.12.1377","https:\u002F\u002Fdoi.org\u002F10.1136\u002Fheart.89.12.1377",{"mag":614,"pmc":615,"openalex":616,"pm":617,"doi":618},"2166611937","1767964","W2166611937","14617534","10.1136\u002Fheart.89.12.1377",{"id":23,"text":620,"url":621,"identifiers":622},"Klein, 1994, Effects of age on left ventricular dimensions and filling dynamics in 117 normal persons, Mayo Clin Proc, 69, 212, 10.1016\u002FS0025-6196(12)61059-3","https:\u002F\u002Fdoi.org\u002F10.1016\u002Fs0025-6196(12)61059-3",{"mag":623,"openalex":624,"pm":625,"doi":626},"1975222570","W1975222570","8133658","10.1016\u002Fs0025-6196(12)61059-3",{"id":23,"text":628,"url":629,"identifiers":630},"Nagueh, 1996, Assessment of left ventricular filling pressures by Doppler in the presence of atrial fibrillation, Circulation, 94, 2138, 10.1161\u002F01.CIR.94.9.2138","https:\u002F\u002Fdoi.org\u002F10.1161\u002F01.cir.94.9.2138",{"mag":631,"openalex":632,"pm":633,"doi":634},"2081183027","W2081183027","8901664","10.1161\u002F01.cir.94.9.2138",{"id":23,"text":636,"url":637,"identifiers":638},"Hurrell, 1998, Short deceleration time of mitral inflow E velocity: prognostic implication with atrial fibrillation versus sinus rhythm, J Am Soc Echocardiogr, 11, 450, 10.1016\u002FS0894-7317(98)70025-2","https:\u002F\u002Fdoi.org\u002F10.1016\u002Fs0894-7317(98)70025-2",{"mag":639,"openalex":640,"pm":641,"doi":642},"1970214216","W1970214216","9619617","10.1016\u002Fs0894-7317(98)70025-2",{"id":23,"text":644,"url":645,"identifiers":646},"Ristow, 2005, Pulmonary regurgitation end-diastolic gradient is a Doppler marker of cardiac status: data from the Heart and Soul Study, J Am Soc Echocardiogr, 18, 885, 10.1016\u002Fj.echo.2005.06.004","https:\u002F\u002Fdoi.org\u002F10.1016\u002Fj.echo.2005.06.004",{"mag":647,"pmc":648,"openalex":649,"pm":650,"doi":651},"2062480028","2776665","W2062480028","16153508","10.1016\u002Fj.echo.2005.06.004",{"id":23,"text":653,"url":654,"identifiers":655},"Drazner, 1999, Relationship between right and left-sided filling pressures in 1000 patients with advanced heart failure, J Heart Lung Transplant, 18, 1126, 10.1016\u002FS1053-2498(99)00070-4","https:\u002F\u002Fdoi.org\u002F10.1016\u002Fs1053-2498(99)00070-4",{"mag":656,"openalex":657,"pm":658,"doi":659},"2145744444","W2145744444","10598737","10.1016\u002Fs1053-2498(99)00070-4",{"id":23,"text":661,"url":662,"identifiers":663},"Sohn, 1997, Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function, J Am Coll Cardiol, 30, 474, 10.1016\u002FS0735-1097(97)88335-0","https:\u002F\u002Fdoi.org\u002F10.1016\u002Fs0735-1097(97)88335-0",{"mag":664,"openalex":665,"pm":666,"doi":667},"1983019374","W1983019374","9247521","10.1016\u002Fs0735-1097(97)88335-0",{"id":23,"text":669,"url":670,"identifiers":671},"Thomas, 1992, Digital analysis of transmitral color Doppler M-mode data: a potential new approach to the noninvasive assessment of diastolic function, Comput Cardiol, 1, 631, 10.1109\u002FCIC.1992.269379","https:\u002F\u002Fdoi.org\u002F10.1109\u002Fcic.1992.269379",{"mag":672,"openalex":673,"doi":674},"2102694558","W2102694558","10.1109\u002Fcic.1992.269379",{"id":23,"text":676,"url":677,"identifiers":678},"Moller, 2000, Ratio of left ventricular peak E-wave velocity to flow propagation velocity assessed by color M-mode Doppler echocardiography in first myocardial infarction: prognostic and clinical implications, J Am Coll Cardiol, 35, 363, 10.1016\u002FS0735-1097(99)00575-6","http:\u002F\u002Fdx.doi.org\u002F10.1016\u002Fs0735-1097(99)00575-6",{"doi":679},"10.1016\u002Fs0735-1097(99)00575-6",{"id":23,"text":681,"url":682,"identifiers":683},"Sorrell, 2001, Noninvasive right and left heart catheterization: taking the echo lab beyond an image-only laboratory, Echocardiography, 18, 31, 10.1046\u002Fj.1540-8175.2001.00031.x","https:\u002F\u002Fdoi.org\u002F10.1046\u002Fj.1540-8175.2001.00031.x",{"mag":684,"openalex":685,"pm":686,"doi":687},"2029134709","W2029134709","11182781","10.1046\u002Fj.1540-8175.2001.00031.x",{"id":689,"text":690,"url":691,"identifiers":692},"3733d0c3-678f-44c3-8029-40321e11a622","Marwick, 2006, Measurement of strain and strain rate by echocardiography: ready for prime time?, J Am Coll Cardiol, 47, 1313, 10.1016\u002Fj.jacc.2005.11.063","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0735109706001628",{"doi":693},"10.1016\u002Fj.jacc.2005.11.063",{"id":23,"text":695,"url":696,"identifiers":697},"Lee, 2004, Prediction of subclinical left ventricular dysfunction with strain rate imaging in patients with asymptomatic severe mitral regurgitation, Am J Cardiol, 94, 1333, 10.1016\u002Fj.amjcard.2004.07.129","https:\u002F\u002Fdoi.org\u002F10.1016\u002Fj.amjcard.2004.07.129",{"mag":698,"openalex":699,"pm":700,"doi":701},"2096453380","W2096453380","15541262","10.1016\u002Fj.amjcard.2004.07.129",{"id":23,"text":703,"url":23,"identifiers":704},"Wong, 2004, Severity of left ventricular remodeling defines outcomes and response to therapy in heart failure: Valsartan heart failure trial (Val-HeFT) echocardiographic data, J Am Coll Cardiol, 43, 2022, 10.1016\u002Fj.jacc.2003.12.053",{"doi":705},"10.1016\u002Fj.jacc.2003.12.053",{"id":23,"text":707,"url":23,"identifiers":708},"Quinones, 2000, Echocardiographic predictors of clinical outcome in patients with left ventricular dysfunction enrolled in the SOLVD registry and trials: significance of left ventricular hypertrophy, J Am Coll Cardiol, 35, 1237, 10.1016\u002FS0735-1097(00)00511-8",{"openalex":709,"doi":710},"W4299322004","10.17615\u002Fsw2k-jr18",{"id":712,"text":713,"url":714,"identifiers":715},"8dd4f70b-a84c-427c-b5ca-a25ef73cfa72","Aronow, 1990, Prognosis of congestive heart failure in elderly patients with normal versus abnormal left ventricular systolic function associated with coronary artery disease, Am J Cardiol, 66, 1257, 10.1016\u002F0002-9149(90)91112-J","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002F000291499091112J",{"doi":716},"10.1016\u002F0002-9149(90)91112-j",{"id":464,"text":718,"url":466,"identifiers":719},"Cohn, 1980, Veterans Administration Cooperative Study Group. Heart failure with normal ejection fraction. The V-HeFT study, Circulation, 81",{"doi":468},{"id":23,"text":721,"url":23,"identifiers":722},"Grayburn, 2005, Echocardiographic predictors of morbidity and mortality in patients with advanced heart failure: the Beta-blocker Evaluation of Survival Trial (BEST), J Am Coll Cardiol, 45, 1064, 10.1016\u002Fj.jacc.2004.12.069",{"doi":723},"10.1016\u002Fj.jacc.2004.12.069",{"id":23,"text":725,"url":726,"identifiers":727},"White, 1987, Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction, Circulation, 76, 44, 10.1161\u002F01.CIR.76.1.44","https:\u002F\u002Fdoi.org\u002F10.1161\u002F01.cir.76.1.44",{"mag":728,"openalex":729,"pm":730,"doi":731},"2088770941","W2088770941","3594774","10.1161\u002F01.cir.76.1.44",{"id":23,"text":733,"url":734,"identifiers":735},"Bruch, 2006, Prognostic value of a restrictive mitral filling pattern in patients with systolic heart failure and an implantable cardioverter-defibrillator, Am J Cardiol, 97, 676, 10.1016\u002Fj.amjcard.2005.09.114","https:\u002F\u002Fdoi.org\u002F10.1016\u002Fj.amjcard.2005.09.114",{"mag":736,"openalex":737,"pm":738,"doi":739},"2125499601","W2125499601","16490436","10.1016\u002Fj.amjcard.2005.09.114",{"id":741,"text":742,"url":743,"identifiers":744},"6a2afd68-fd54-4415-a0b9-24131c8dc05a","Liang, 2006, Comparison of usefulness of echocardiographic Doppler variables to left ventricular end-diastolic pressure in predicting future heart failure events, Am J Cardiol, 97, 866, 10.1016\u002Fj.amjcard.2005.09.136","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0002914905021119",{"doi":745},"10.1016\u002Fj.amjcard.2005.09.136",{"id":23,"text":747,"url":748,"identifiers":749},"Klein, 1991, Prognostic significance of Doppler measures of diastolic function in cardiac amyloidosis: a Doppler echocardiography study, Circulation, 83, 808, 10.1161\u002F01.CIR.83.3.808","https:\u002F\u002Fdoi.org\u002F10.1161\u002F01.cir.83.3.808",{"mag":750,"openalex":751,"pm":752,"doi":753},"2008973386","W2008973386","1999031","10.1161\u002F01.cir.83.3.808",{"id":23,"text":755,"url":756,"identifiers":757},"Vanoverschelde, 1990, Left ventricular filling in dilated cardiomyopathy: relation to functional class and hemodynamics, J Am Coll Cardiol, 15, 1288, 10.1016\u002FS0735-1097(10)80016-6","http:\u002F\u002Fdx.doi.org\u002F10.1016\u002Fs0735-1097(10)80016-6",{"doi":758},"10.1016\u002Fs0735-1097(10)80016-6",{"id":23,"text":760,"url":761,"identifiers":762},"Pozzoli, 1997, Loading manipulation improves the prognostic value of Doppler evaluation of mitral valve flow in patients with chronic heart failure, Circulation, 95, 1222, 10.1161\u002F01.CIR.95.5.1222","http:\u002F\u002Fdx.doi.org\u002F10.1161\u002F01.cir.95.5.1222",{"doi":763},"10.1161\u002F01.cir.95.5.1222",{"id":23,"text":765,"url":766,"identifiers":767},"Temporelli, 1998, Reversible restrictive left ventricular diastolic filling with optimized oral therapy predicts a more favorable prognosis in patients with chronic heart failure, J Am Coll Cardiol, 31, 1591, 10.1016\u002FS0735-1097(98)00165-X","https:\u002F\u002Fdoi.org\u002F10.1016\u002Fs0735-1097(98)00165-x",{"mag":768,"openalex":769,"pm":770,"doi":771},"2037733417","W2037733417","9626839","10.1016\u002Fs0735-1097(98)00165-x",{"id":23,"text":773,"url":23,"identifiers":774},"Duncan, 2005, Effect of dobutamine stress on left ventricular filling in ischemic dilated cardiomyopathy: pathophysiology and prognostic implications, J Am Coll Cardiol, 46, 488, 10.1016\u002Fj.jacc.2005.04.048",{"doi":775},"10.1016\u002Fj.jacc.2005.04.048",{"id":23,"text":777,"url":778,"identifiers":779},"Nath, 2006, A dilated inferior vena cava is a marker of poor survival, Am Heart J, 151, 730, 10.1016\u002Fj.ahj.2005.04.023","https:\u002F\u002Fdoi.org\u002F10.1016\u002Fj.ahj.2005.04.023",{"mag":780,"openalex":781,"pm":782,"doi":783},"2135733350","W2135733350","16504642","10.1016\u002Fj.ahj.2005.04.023",{"id":785,"text":786,"url":787,"identifiers":788},"db86a4e2-124c-4827-98a6-ae5cb9e8160b","De Groote, 1998, Right ventricular ejection fraction is an independent predictor of survival in patients with moderate heart failure, J Am Coll Cardiol, 32, 948, 10.1016\u002FS0735-1097(98)00337-4","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0735109798003374",{"doi":789},"10.1016\u002Fs0735-1097(98)00337-4",{"id":23,"text":791,"url":792,"identifiers":793},"Hung, 1998, Usefulness of echocardiographic determined tricuspid regurgitation in predicting event-free survival in severe heart failure secondary to idiopathic-dilated cardiomyopathy or to ischemic cardiomyopathy, Am J Cardiol, 82, 1301, 10.1016\u002FS0002-9149(98)00624-9","https:\u002F\u002Fdoi.org\u002F10.1016\u002Fs0002-9149(98)00624-9",{"mag":794,"openalex":795,"pm":796,"doi":797},"2057572267","W2057572267","9832116","10.1016\u002Fs0002-9149(98)00624-9",{"id":23,"text":799,"url":800,"identifiers":801},"Redfield, 2003, Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic, JAMA, 289, 194, 10.1001\u002Fjama.289.2.194","https:\u002F\u002Fdoi.org\u002F10.1016\u002Fs1062-1458(03)00178-8",{"mag":802,"openalex":803,"doi":804},"2056395153","W2056395153","10.1016\u002Fs1062-1458(03)00178-8",{"id":23,"text":806,"url":807,"identifiers":808},"Mosterd, 1999, Prevalence of heart failure and left ventricular dysfunction in the general population: the Rotterdam study, Eur Heart J, 20, 447, 10.1053\u002Feuhj.1998.1239","https:\u002F\u002Fdoi.org\u002F10.1053\u002Feuhj.1998.1239",{"mag":809,"openalex":810,"pm":811,"doi":812},"2007946529","W2007946529","10213348","10.1053\u002Feuhj.1998.1239",{"id":23,"text":814,"url":815,"identifiers":816},"Davies, 2001, Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening Study: a population-based study, Lancet, 358, 439, 10.1016\u002FS0140-6736(01)05620-3","https:\u002F\u002Fdoi.org\u002F10.1016\u002Fs0140-6736(01)05620-3",{"mag":817,"openalex":818,"pm":819,"doi":820},"2139552008","W2139552008","11513906","10.1016\u002Fs0140-6736(01)05620-3",{"id":822,"text":823,"url":824,"identifiers":825},"4f23fcbc-7827-4422-a339-9934605ffb47","McDonagh, 1997, Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population, Lancet, 350, 829, 10.1016\u002FS0140-6736(97)03033-X","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS014067369703033X",{"doi":826},"10.1016\u002Fs0140-6736(97)03033-x",{"id":828,"text":829,"url":830,"identifiers":831},"33128cbb-7c84-463f-8e68-65bca6a15066","Devereux, 2001, A population-based assessment of left ventricular systolic dysfunction in middle-aged and older adults: the Strong Heart Study, Am Heart J, 141, 439, 10.1067\u002Fmhj.2001.113223","https:\u002F\u002Flinkinghub.elsevier.com\u002Fretrieve\u002Fpii\u002FS000287030105788X",{"doi":832},"10.1067\u002Fmhj.2001.113223",{"id":464,"text":834,"url":466,"identifiers":835},"Abhayaratna, 2006, Prevalence of heart failure and systolic ventricular dysfunction in older Australians: the Canberra Heart Study, MJA, 184, 151",{"doi":468},{"id":23,"text":837,"url":838,"identifiers":839},"Kannel, 1987, Epidemiology and prevention of cardiac failure: Framingham Study insights, Eur Heart J, 8, 23, 10.1093\u002Feurheartj\u002F8.suppl_F.23","https:\u002F\u002Fdoi.org\u002F10.1093\u002Feurheartj\u002F8.suppl_f.23",{"mag":840,"openalex":841,"pm":842,"doi":843},"1985881365","W1985881365","3665963","10.1093\u002Feurheartj\u002F8.suppl_f.23",{"id":845,"text":846,"url":847,"identifiers":848},"7746972c-57ea-4247-9ca4-7f17a746948a","Koilpillai, 1996, Relation of ventricular size and function to heart failure status and ventricular dysrhythmia in patients with severe left ventricular dysfunction, Am J Cardiol, 78, 606, 10.1016\u002FS0002-9149(97)89315-0","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0002914997893150",{"doi":849},"10.1016\u002Fs0002-9149(97)89315-0",{"id":23,"text":851,"url":852,"identifiers":853},"Senni, 1999, Use of echocardiography in the management of congestive heart failure in the community, J Am Coll Cardiol, 33, 164, 10.1016\u002FS0735-1097(98)00523-3","https:\u002F\u002Fdoi.org\u002F10.1016\u002Fs0735-1097(98)00523-3",{"mag":854,"openalex":855,"pm":856,"doi":857},"2080762212","W2080762212","9935024","10.1016\u002Fs0735-1097(98)00523-3",{"id":859,"createTime":860,"updateTime":861,"relativeEntities":862,"slug":863,"properties":864,"entityType":119,"verifyStatus":120,"verifyTime":861,"verifyNote":122,"languages":23,"translateLanguages":23,"viewCount":24,"primaryUrl":871,"fullTextUrl":23,"authors":872,"publicationType":157,"publisherRelationship":901,"citationCount":23,"citationInfo":23,"publishDate":953,"publishYear":212,"citationAnalyzeStatus":22,"lastCitationAnalyze":23,"indexDatabases":954,"openAccess":23,"references":23,"isForceReanalyzing":215},"8fe3a942-e07a-4527-b168-9cc634f0d17a","2023-12-06T09:31:58.500+00:00","2025-02-20T13:18:56.264+00:00",[],"Biomarkers-of-Myocyte-Injury-in-Heart-Failure",{"title":865,"references":867,"doi":869},{"EN":866},"Biomarkers of Myocyte Injury in Heart Failure",{"VOID":868},"Thygesen, 2007, Joint ESC\u002FACCF\u002FAHA\u002FWHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction, Circulation, 116, 2634, 10.1161\u002FCIRCULATIONAHA.107.187397\nSaenger, 2008, Requiem for a heavyweight: the demise of creatine kinase-MB, Circulation, 118, 2200, 10.1161\u002FCIRCULATIONAHA.108.773218\nOlivetti, 1991, Cardiomyopathy of the aging human heart. Myocyte loss and reactive cellular hypertrophy, Circ Res, 68, 1560, 10.1161\u002F01.RES.68.6.1560\nOlivetti, 1995, Gender differences and aging: effects on the human heart, J Am Coll Cardiol, 26, 1068, 10.1016\u002F0735-1097(95)00282-8\nAnversa, 1996, Myocyte death in heart failure, Curr Opin Cardiol, 11, 245, 10.1097\u002F00001573-199605000-00004\nMudd, 2008, Tackling heart failure in the twenty-first century, Nature, 451, 919, 10.1038\u002Fnature06798\nCapasso, 1992, Chronic nonocclusive coronary artery constriction impairs ventricular function, myocardial structure, and cardiac contractile protein enzyme activity in rats, Circ Res, 70, 148, 10.1161\u002F01.RES.70.1.148\nOlivetti, 1997, Apoptosis in the failing human heart, N Engl J Med, 336, 1131, 10.1056\u002FNEJM199704173361603\nNarula, 1999, Apoptosis in heart failure: release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy, Proc Natl Acad Sci U S A, 96, 8144, 10.1073\u002Fpnas.96.14.8144\nSobel, 2000, Ingenuous interpretation of elevated blood levels of macromolecular markers of myocardial injury: a recipe for confusion, J Am Coll Cardiol, 35, 1355, 10.1016\u002FS0735-1097(00)00516-7\nHerman, 1998, Use of cardiac troponin T levels as an indicator of doxorubicin-induced cardiotoxicity, Cancer Res, 58, 195\nFishbein, 2003, Myocardial tissue troponins T and I. An immunohistochemical study in experimental models of myocardial ischemia, Cardiovasc Pathol, 12, 65, 10.1016\u002FS1054-8807(02)00188-6\nZhang, 2008, Isoproterenol-induced cardiotoxicity in Sprague-Dawley rats: correlation of reversible and irreversible myocardial injury with release of cardiac troponin T and roles of iNOS in myocardial injury, Toxicol Pathol, 36, 277, 10.1177\u002F0192623307313010\nO'Brien, 2008, Cardiac troponin is the most effective translational safety biomarker for myocardial injury in cardiotoxicity, Toxicology, 245, 206, 10.1016\u002Fj.tox.2007.12.006\nApple, 2008, for the HESI Technical Committee of Biomarkers Working Group on Cardiac Troponins. Analytical characteristics of commercial cardiac troponin I and T immunoassays in serum from rats, dogs, and monkeys with induced acute myocardial injury, Clin Chem, 54, 1982, 10.1373\u002Fclinchem.2007.097568\nDolci, 2008, Biochemical markers for prediction of chemotherapy-induced cardiotoxicity: systematic review of the literature and recommendations for use, Am J Clin Pathol, 130, 688, 10.1309\u002FAJCPB66LRIIVMQDR\nMingels, 2009, Reference population and marathon runner sera assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and I assays, Clin Chem, 55, 101, 10.1373\u002Fclinchem.2008.106427\nWallace, 2006, Prevalence and determinants of troponin T elevation in the general population, Circulation, 113, 1958, 10.1161\u002FCIRCULATIONAHA.105.609974\nWu, 2006, Development and preliminary clinical validation of a high sensitivity assay for cardiac troponin using a capillary flow (single molecule) fluorescence detector, Clin Chem, 52, 2157, 10.1373\u002Fclinchem.2006.073163\nClerico, 2008, Distribution of plasma cardiac troponin I values in healthy subjects: pathophysiological considerations, Clin Chem Lab Med, 46, 804, 10.1515\u002FCCLM.2008.162\nJeremias, 2005, Narrative review: alternative causes for elevated cardiac troponin levels when acute coronary syndromes are excluded, Ann Intern Med, 142, 786, 10.7326\u002F0003-4819-142-9-200505030-00015\nLa Vecchia, 1997, Detectable serum troponin I in patients with heart failure of nonmyocardial ischemic origin, Am J Cardiol, 80, 88, 10.1016\u002FS0002-9149(97)00291-9\nMissov, 1997, Circulating cardiac troponin I in severe congestive heart failure, Circulation, 96, 2953, 10.1161\u002F01.CIR.96.9.2953\nSato, 2001, Persistently increased serum concentrations of cardiac troponin T in patients with idiopathic dilated cardiomyopathy are predictive of adverse outcomes, Circulation, 103, 369, 10.1161\u002F01.CIR.103.3.369\nSetsuta, 2002, Use of cytosolic and myofibril markers in the detection of ongoing myocardial damage in patients with chronic heart failure, Am J Med, 113, 717, 10.1016\u002FS0002-9343(02)01394-3\nIshii, 2002, Risk stratification using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failure, Am J Cardiol, 89, 691, 10.1016\u002FS0002-9149(01)02341-4\nHealey, 2003, Prognostic use of cardiac troponin T and troponin I in patients with heart failure, Can J Cardiol, 19, 383\nPerna, 2004, Ongoing myocardial injury in stable severe heart failure: value of cardiac troponin T monitoring for high-risk patient identification, Circulation, 110, 2376, 10.1161\u002F01.CIR.0000145158.33801.F3\nIshii, 2003, Prognostic value of combination of cardiac troponin T and B-type natriuretic peptide after initiation of treatment in patients with chronic heart failure, Clin Chem, 49, 2020, 10.1373\u002Fclinchem.2003.021311\nBertinchant, 2005, Prognostic value of cardiac troponin T in patients with both acute and chronic stable congestive heart failure: comparison with atrial natriuretic peptide, brain natriuretic peptide and plasma norepinephrine, Clin Chim Acta, 352, 143, 10.1016\u002Fj.cccn.2004.09.009\nPeacock, 2008, Cardiac troponin and outcome in acute heart failure, N Engl J Med, 358, 2117, 10.1056\u002FNEJMoa0706824\nHudson, 2004, Implications of elevated cardiac troponin T in ambulatory patients with heart failure: a prospective analysis, Am Heart J, 147, 546, 10.1016\u002Fj.ahj.2003.10.014\nLatini, 2007, Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure, Circulation, 116, 1242, 10.1161\u002FCIRCULATIONAHA.106.655076\nCohn, 2001, Valsartan heart failure trial investigators. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure, N Engl J Med, 345, 1667, 10.1056\u002FNEJMoa010713\nApple, 2008, Use of the Centaur TnI-Ultra assay for detection of myocardial infarction and adverse events in patients presenting with symptoms suggestive of acute coronary syndrome, Clin Chem, 54, 723, 10.1373\u002Fclinchem.2007.097162\nLogeart, 2001, Evidence of cardiac myolysis in severe nonischemic heart failure and the potential role of increased wall strain, Am Heart J, 141, 247, 10.1067\u002Fmhj.2001.111767\nKurz, 2008, Highly sensitive cardiac troponin T values remain constant after brief exercise- or pharmacologic-induced reversible myocardial ischemia, Clin Chem, 54, 1234, 10.1373\u002Fclinchem.2007.097865\nBraunwald, 2008, Biomarkers in heart failure, N Engl J Med, 358, 2148, 10.1056\u002FNEJMra0800239\nDel Carlo, 2004, Serial measure of cardiac troponin T levels for prediction of clinical events in decompensated heart failure, J Card Fail, 10, 43, 10.1016\u002FS1071-9164(03)00594-3\nGoto, 2003, Circulating concentrations of cardiac proteins indicate the severity of congestive heart failure, Heart, 89, 1303, 10.1136\u002Fheart.89.11.1303\nArimoto, 2005, Prognostic value of elevated circulating heart-type fatty acid binding protein in patients with congestive heart failure, J Card Fail, 11, 56, 10.1016\u002Fj.cardfail.2004.03.005\nNiizeki, 2008, Persistently increased serum concentration of heart-type fatty acid-binding protein predicts adverse clinical outcomes in patients with chronic heart failure, Circ J, 72, 109, 10.1253\u002Fcircj.72.109\nNiizeki, 2007, Heart-type fatty acid-binding protein is more sensitive than troponin T to detect the ongoing myocardial damage in chronic heart failure patients, J Card Fail, 13, 120, 10.1016\u002Fj.cardfail.2006.10.014\nSetsuta, 2008, Elevated levels of both cardiomyocyte membrane and myofibril damage markers predict adverse outcomes in patients with chronic heart failure, Circ J, 72, 569, 10.1253\u002Fcircj.72.569\nMorrow, 2007, National Academy of Clinical Biochemistry laboratory medicine practice guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes, Circulation, 115, e356, 10.1161\u002FCIRCULATIONAHA.107.182882\nSugiura, 2005, Circulating levels of myocardial proteins predict future deterioration of congestive heart failure, J Card Fail, 11, 504, 10.1016\u002Fj.cardfail.2005.04.025\nHansen, 2002, Relation of circulating cardiac myosin light chain 1 isoform in stable severe congestive heart failure to survival and treatment with flosequinan, Am J Cardiol, 90, 969, 10.1016\u002FS0002-9149(02)02663-2\nWhite, 2008, Will new higher-precision troponins lead to clarity or confusion?, Curr Opin Cardiol, 23, 292, 10.1097\u002FHCO.0b013e3283050808\nWu, 2008, The clinical need for high-sensitivity cardiac troponin assays for acute coronary syndromes and the role for serial testing, Am Heart J, 155, 208, 10.1016\u002Fj.ahj.2007.10.016\nWang, 2007, Significance of circulating troponins in heart failure: if these walls could talk, Circulation, 116, 1217, 10.1161\u002FCIRCULATIONAHA.107.721845\nZethelius, 2008, Use of multiple biomarkers to improve the prediction of death from cardiovascular causes, N Engl J Med, 358, 2107, 10.1056\u002FNEJMoa0707064",{"VOID":870},"10.1016\u002Fj.hfc.2009.04.008","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS155171360900035X",[873,888],{"id":874,"sortIndex":24,"researcher":23,"roles":875,"affiliations":876,"properties":885},"f2f448d1-5f60-4d40-bf7a-d32af9c23669",[128],[877],{"id":878,"sortIndex":24,"affiliation":879,"properties":23},"194f05fa-389f-4ec9-b7c8-8606e3c0bfa8",{"id":878,"createTime":23,"updateTime":23,"relativeEntities":880,"slug":23,"properties":881,"entityType":23,"verifyStatus":23,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":23,"url":23,"parentIds":884,"statistic":23},[],{"title":882},{"VI":883},"Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy",[],{"title":886},{"VI":887},"Roberto Latini",{"id":889,"sortIndex":143,"researcher":23,"roles":890,"affiliations":891,"properties":898},"de395db9-bd48-4d75-acf3-d87d80d7109d",[128],[892],{"id":878,"sortIndex":24,"affiliation":893,"properties":23},{"id":878,"createTime":23,"updateTime":23,"relativeEntities":894,"slug":23,"properties":895,"entityType":23,"verifyStatus":23,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":23,"url":23,"parentIds":897,"statistic":23},[],{"title":896},{"VI":883},[],{"title":899},{"VI":900},"Serge Masson",{"url":871,"publisher":902,"properties":949},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":903,"slug":10,"properties":904,"entityType":21,"verifyStatus":22,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":24,"subjectFields":909,"manageAffiliations":918,"indexDatabases":929,"url":89,"thumbnailPath":23,"statistic":944,"gsStatistic":23,"type":23,"analyzePriority":23},[],{"country":905,"eissn":906,"issn":907,"title":908},{"VOID":13},{"VOID":15},{"VOID":15},{"EN":18},[910,914],{"id":27,"createTime":23,"updateTime":23,"relativeEntities":911,"label":912,"description":913,"parentId":23,"standard":23,"scholarHubFieldId":23},[],{"EN":30},{},{"id":33,"createTime":23,"updateTime":23,"relativeEntities":915,"label":916,"description":917,"parentId":23,"standard":23,"scholarHubFieldId":23},[],{"EN":36},{},[919,924],{"id":40,"createTime":23,"updateTime":23,"relativeEntities":920,"slug":23,"properties":921,"entityType":23,"verifyStatus":23,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":23,"url":23,"parentIds":923,"statistic":23},[],{"title":922},{"EN":44},[],{"id":47,"createTime":23,"updateTime":23,"relativeEntities":925,"slug":23,"properties":926,"entityType":23,"verifyStatus":23,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":23,"url":23,"parentIds":928,"statistic":23},[],{"title":927},{"EN":51},[],[930,937],{"id":55,"indexDatabase":931,"url":66,"indexYears":67,"academicFieldIds":936,"indexDatabaseRanking":71},{"id":57,"createTime":23,"updateTime":23,"relativeEntities":932,"label":933,"description":934,"key":63,"publicationTags":935,"standard":23},[],{"EN":60,"VI":60},{"EN":60,"VI":62},[65],[69,70],{"id":73,"indexDatabase":938,"url":86,"indexYears":23,"academicFieldIds":943,"indexDatabaseRanking":23},{"id":75,"createTime":23,"updateTime":23,"relativeEntities":939,"label":940,"description":941,"key":82,"publicationTags":942,"standard":23},[],{"EN":78,"VI":78},{"EN":80,"VI":81},[84,85],[88],{"impactFactor":24,"impactFactorByYear":945,"i10Index":24,"i10IndexLast5Year":24,"totalPublication":92,"totalPublicationByYear":946,"totalCitation":24,"totalCitationByYear":947,"totalCitationPerPublication":24,"totalCitationPerPublicationByYear":948,"hindexLast5Year":24,"hindex":24},{},{"2007":94,"2008":95,"2009":96,"2011":97},{},{},{"pages":950,"volume":952},{"VOID":951},"529-536",{"VOID":210},"2009-10-01",[71,84],{"id":956,"createTime":957,"updateTime":958,"relativeEntities":959,"slug":960,"properties":961,"entityType":119,"verifyStatus":120,"verifyTime":958,"verifyNote":122,"languages":23,"translateLanguages":23,"viewCount":24,"primaryUrl":968,"fullTextUrl":23,"authors":969,"publicationType":157,"publisherRelationship":998,"citationCount":23,"citationInfo":23,"publishDate":1051,"publishYear":1052,"citationAnalyzeStatus":22,"lastCitationAnalyze":23,"indexDatabases":1053,"openAccess":23,"references":23,"isForceReanalyzing":215},"31824ef3-daba-446c-b0cc-c2c90ac62481","2023-12-07T12:37:35.687+00:00","2025-02-19T13:45:34.179+00:00",[],"Natriuretic-Peptides-and-Filling-Pressure-at-Rest-and-Stress",{"title":962,"references":964,"doi":966},{"EN":963},"Natriuretic Peptides and Filling Pressure at Rest and Stress",{"VOID":965},"Weber, 2006, Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine, Heart, 92, 843, 10.1136\u002Fhrt.2005.071233\nVanderheyden, 2004, Brain and other natriuretic peptides: molecular aspects, Eur J Heart Fail, 6, 261, 10.1016\u002Fj.ejheart.2004.01.004\nHall, 2004, Essential biochemistry and physiology of (NT-pro)BNP, Eur J Heart Fail, 6, 257, 10.1016\u002Fj.ejheart.2003.12.015\nMantymaa, 1993, Atrial stretch induces rapid increase in brain natriuretic peptide but not in atrial natriuretic peptide gene expression in vitro, Endocrinology, 133, 1470, 10.1210\u002Fen.133.3.1470\nMukoyama, 1991, Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide, J Clin Invest, 87, 1402, 10.1172\u002FJCI115146\nWoods, 2004, Cardioprotective functions of atrial natriuretic peptide and B-type natriuretic peptide: a brief review, Clin Exp Pharmacol Physiol, 31, 791, 10.1111\u002Fj.0305-1870.2004.04073.x\nItoh, 1990, Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells, J Clin Invest, 86, 1690, 10.1172\u002FJCI114893\nCao, 1995, Natriuretic peptides inhibit DNA synthesis in cardiac fibroblasts, Hypertension, 25, 227, 10.1161\u002F01.HYP.25.2.227\nSmith, 2000, Delayed metabolism of human brain natriuretic peptide reflects resistance to neutral endopeptidase, J Endocrinol, 167, 239, 10.1677\u002Fjoe.0.1670239\nBruneau, 1997, BNP gene expression is specifically modulated by stretch and ET-1 in a new model of isolated rat atria, Am J Physiol, 273, H2678\nWiese, 2000, Gene expression of brain natriuretic peptide in isolated atrial and ventricular human myocardium: influence of angiotensin II and diastolic fiber length, Circulation, 102, 3074, 10.1161\u002F01.CIR.102.25.3074\nBibbins-Domingo, 2003, B-type natriuretic peptide and ischemia in patients with stable coronary disease: data from the Heart and Soul study, Circulation, 108, 2987, 10.1161\u002F01.CIR.0000103681.04726.9C\nRiddervold, 1991, Rate-induced increase in plasma atrial natriuretic factor can occur independently of changes in atrial wall stretch, Am J Physiol, 260, H1953\nNishimori, 1997, Dexamethasone-induced up-regulation of adrenomedullin and atrial natriuretic peptide genes in cultured rat ventricular myocytes, J Mol Cell Cardiol, 29, 2125, 10.1006\u002Fjmcc.1997.0460\nTsutamoto, 2007, Direct comparison of transcardiac difference between brain natriuretic peptide (BNP) and N-terminal pro-BNP in patients with chronic heart failure, Eur J Heart Fail, 9, 667, 10.1016\u002Fj.ejheart.2007.01.003\nMcCullough, 2003, B-type natriuretic peptide and renal disease, Heart Fail Rev, 8, 355, 10.1023\u002FA:1026195332025\nForfia, 2005, Relationship between B-type natriuretic peptides and pulmonary capillary wedge pressure in the intensive care unit, J Am Coll Cardiol, 45, 1667, 10.1016\u002Fj.jacc.2005.01.046\nHubert, 1983, Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study, Circulation, 67, 968, 10.1161\u002F01.CIR.67.5.968\nTaylor, 2006, B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide are depressed in obesity despite higher left ventricular end diastolic pressures, Am Heart J, 152, 1071, 10.1016\u002Fj.ahj.2006.07.010\nWang, 2004, Impact of obesity on plasma natriuretic peptide levels, Circulation, 109, 594, 10.1161\u002F01.CIR.0000112582.16683.EA\nKrauser, 2005, Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of dyspnea in the emergency department (PRIDE) substudy, Am Heart J, 149, 744, 10.1016\u002Fj.ahj.2004.07.010\nBrown, 2006, B-type natriuretic peptide level in a patient with constrictive pericarditis, Catheter Cardiovasc Interv, 68, 832, 10.1002\u002Fccd.20784\nWolozin, 1988, Release of atrial natriuretic factor after pericardiectomy for chronic constrictive pericarditis, Am J Cardiol, 62, 1323, 10.1016\u002F0002-9149(88)90291-3\nSvanegaard, 1990, Atrial natriuretic peptide and hemodynamic response to pericardiectomy for chronic constrictive pericarditis, Am J Cardiol, 66, 117, 10.1016\u002F0002-9149(90)90750-U\nLeya, 2005, The efficacy of brain natriuretic peptide levels in differentiating constrictive pericarditis from restrictive cardiomyopathy, J Am Coll Cardiol, 45, 1900, 10.1016\u002Fj.jacc.2005.03.050\nWatanabe, 2006, Myocardial stiffness is an important determinant of the plasma brain natriuretic peptide concentration in patients with both diastolic and systolic heart failure, Eur Heart J, 27, 832, 10.1093\u002Feurheartj\u002Fehi772\nIwanaga, 2006, B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure, J Am Coll Cardiol, 47, 742, 10.1016\u002Fj.jacc.2005.11.030\nMaeda, 1998, Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction, Am Heart J, 135, 825, 10.1016\u002FS0002-8703(98)70041-9\nMair, 2007, B-type natriuretic peptide (BNP) is more sensitive to rapid hemodynamic changes in acute heart failure than N-terminal proBNP, Clin Chim Acta, 379, 163, 10.1016\u002Fj.cca.2006.12.018\nKazanegra, 2001, A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study, J Card Fail, 7, 21, 10.1054\u002Fjcaf.2001.23355\nTroughton, 2004, Plasma B-type natriuretic peptide levels in systolic heart failure: importance of left ventricular diastolic function and right ventricular systolic function, J Am Coll Cardiol, 43, 416, 10.1016\u002Fj.jacc.2003.08.046\nParsonage, 2005, Value of B-type natriuretic peptide for identifying significantly elevated pulmonary artery wedge pressure in patients treated for established chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy, Am J Cardiol, 95, 883, 10.1016\u002Fj.amjcard.2004.12.021\nKuster, 2002, B-type natriuretic peptide for diagnosis and treatment of congestive heart failure, Swiss Med Wkly, 132, 623\nO'Neill, 2005, B-type natriuretic peptide levels are not a surrogate marker for invasive hemodynamics during management of patients with severe heart failure, Am Heart J, 149, 363, 10.1016\u002Fj.ahj.2004.05.051\nTschope, 2005, The role of NT-proBNP in the diagnostics of isolated diastolic dysfunction: correlation with echocardiographic and invasive measurements, Eur Heart J, 26, 2277, 10.1093\u002Feurheartj\u002Fehi406\nVanderheyden, 2004, Wall stress modulates brain natriuretic peptide production in pressure overload cardiomyopathy, J Am Coll Cardiol, 44, 2349, 10.1016\u002Fj.jacc.2004.09.038\nMottram, 2003, Usefulness of B-type natriuretic peptide in hypertensive patients with exertional dyspnea and normal left ventricular ejection fraction and correlation with new echocardiographic indexes of systolic and diastolic function, Am J Cardiol, 92, 1434, 10.1016\u002Fj.amjcard.2003.08.053\nMottram, 2004, Response of B-type natriuretic peptide to exercise in hypertensive patients with suspected diastolic heart failure: correlation with cardiac function, hemodynamics, and workload, Am Heart J, 148, 365, 10.1016\u002Fj.ahj.2004.02.012\nFukuta, 2007, Elevated left ventricular filling pressure after maximal exercise predicts increased plasma B-type natriuretic peptide levels in patients with impaired relaxation pattern of diastolic filling, J Am Soc Echocardiogr, 20, 832, 10.1016\u002Fj.echo.2007.01.004\nJoung, 2005, Can pro-brain natriuretic peptide be used as a noninvasive predictor of elevated left ventricular diastolic pressures in patients with normal systolic function?, Am Heart J, 150, 1213, 10.1016\u002Fj.ahj.2005.01.014\nAbhayaratna, 2006, Population-based detection of systolic and diastolic dysfunction with amino-terminal pro-B-type natriuretic peptide, Am Heart J, 152, 941, 10.1016\u002Fj.ahj.2006.05.007\nDahlstrom, 2004, Can natriuretic peptides be used for the diagnosis of diastolic heart failure?, Eur J Heart Fail, 6, 281, 10.1016\u002Fj.ejheart.2004.01.005\nRedfield, 2004, Plasma brain natriuretic peptide to detect preclinical ventricular systolic or diastolic dysfunction: a community-based study, Circulation, 109, 3176, 10.1161\u002F01.CIR.0000130845.38133.8F\nHaug, 1993, Plasma brain natriuretic peptide and atrial natriuretic peptide concentrations correlate with left ventricular end-diastolic pressure, Clin Cardiol, 16, 553, 10.1002\u002Fclc.4960160708\nOmland, 1996, Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairment, Heart, 76, 232, 10.1136\u002Fhrt.76.3.232\nPfister, 2004, Use of NT-proBNP in routine testing and comparison to BNP, Eur J Heart Fail, 6, 289, 10.1016\u002Fj.ejheart.2003.12.012\nMarz, 2007, N-terminal pro-B-type natriuretic peptide predicts total and cardiovascular mortality in individuals with or without stable coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health Study, Clin Chem, 53, 1075, 10.1373\u002Fclinchem.2006.075929\nDokainish, 2004, Optimal noninvasive assessment of left ventricular filling pressures: a comparison of tissue Doppler echocardiography and B-type natriuretic peptide in patients with pulmonary artery catheters, Circulation, 109, 2432, 10.1161\u002F01.CIR.0000127882.58426.7A\nTung, 2004, Utility of B-type natriuretic peptide for the evaluation of intensive care unit shock, Crit Care Med, 32, 1643, 10.1097\u002F01.CCM.0000133694.28370.7F\nShah, 2005, Impact of the pulmonary artery catheter in critically Ill patients: meta-analysis of randomized clinical trials, JAMA, 294, 1664, 10.1001\u002Fjama.294.13.1664\nKnebel, 2005, NT-ProBNP in acute heart failure: correlation with invasively measured hemodynamic parameters during recompensation, J Card Fail, 11, S38, 10.1016\u002Fj.cardfail.2005.04.012\nGegenhuber, 2004, Time course of B-type natriuretic peptide (BNP) and N-terminal proBNP changes in patients with decompensated heart failure, Clin Chem, 50, 454, 10.1373\u002Fclinchem.2003.028712\nTroughton, 2006, BNP for clinical monitoring of heart failure, Heart Fail Clin, 2, 333, 10.1016\u002Fj.hfc.2006.08.006\nO'Hanlon, 2007, The biologic variability of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide in stable heart failure patients, J Card Fail, 13, 50, 10.1016\u002Fj.cardfail.2006.09.003\nHare, 2008, Performance of conventional echocardiographic parameters and myocardial measurements in the sequential evaluation of left ventricular ejection function, Am J Cardiol, 10.1016\u002Fj.amjcard.2007.10.037\nPetrie, 2004, Poor concordance of commonly used echocardiographic measures of left ventricular diastolic function in patients with suspected heart failure but preserved systolic function: is there a reliable echocardiographic measure of diastolic dysfunction?, Heart, 90, 511, 10.1136\u002Fhrt.2003.011403\nBurgess, 2006, Diastolic stress echocardiography: hemodynamic validation and clinical significance of estimation of ventricular filling pressure with exercise, J Am Coll Cardiol, 47, 1891, 10.1016\u002Fj.jacc.2006.02.042\nWijbenga, 1999, Cardiac peptides differ in their response to exercise. Implications for patients with heart failure in clinical practice, Eur Heart J, 20, 1424, 10.1053\u002Feuhj.1999.1630\nTanaka, 1995, Exercise-induced secretion of brain natriuretic peptide in essential hypertension and normal subjects, Hypertens Res, 18, 159, 10.1291\u002Fhypres.18.159\nHuang, 2002, Circulating brain natriuretic peptide values in healthy men before and after exercise, Metabolism, 51, 1423, 10.1053\u002Fmeta.2002.35194\nSteele, 1997, Responses of atrial natriuretic peptide and brain natriuretic peptide to exercise in patients with chronic heart failure and normal control subjects, Eur J Clin Invest, 27, 270, 10.1046\u002Fj.1365-2362.1997.1070653.x\nNishikimi, 1997, Different secretion patterns of adrenomedullin, brain natriuretic peptide, and atrial natriuretic peptide during exercise in hypertensive and normotensive subjects, Clin Exp Hypertens, 19, 503, 10.3109\u002F10641969709084511\nFriedl, 1999, Relationship between natriuretic peptides and hemodynamics in patients with heart failure at rest and after ergometric exercise, Clin Chim Acta, 281, 121, 10.1016\u002FS0009-8981(98)00217-4\nIkeda, 2007, N-terminal pro-atrial natriuretic peptide and exercise prescription in patients with myocardial infarction, Regul Pept, 141, 154, 10.1016\u002Fj.regpep.2006.12.024\nKohno, 1992, Pulmonary arterial brain natriuretic peptide concentration and cardiopulmonary hemodynamics during exercise in patients with essential hypertension, Metabolism, 41, 1273, 10.1016\u002F0026-0495(92)90095-R\nTschope, 2005, Elevated NT-ProBNP levels in patients with increased left ventricular filling pressure during exercise despite preserved systolic function, J Card Fail, 11, S28, 10.1016\u002Fj.cardfail.2005.04.013\nYoshimura, 1993, Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure, Circulation, 87, 464, 10.1161\u002F01.CIR.87.2.464\nMatsumoto, 1995, Effects of exercise on plasma level of brain natriuretic peptide in congestive heart failure with and without left ventricular dysfunction, Am Heart J, 129, 139, 10.1016\u002F0002-8703(95)90054-3\nRichards, 1993, Brain natriuretic factor: regional plasma concentrations and correlations with haemodynamic state in cardiac disease, Br Heart J, 69, 414, 10.1136\u002Fhrt.69.5.414\nMuders, 1997, Evaluation of plasma natriuretic peptides as markers for left ventricular dysfunction, Am Heart J, 134, 442, 10.1016\u002FS0002-8703(97)70079-6\nLa Vecchia, 1998, Hemodynamic correlates of atrial natriuretic peptide concentration in unselected patients with heart disease of different etiologies, G Ital Cardiol, 28, 1363\nVinereanu, 2005, Reduced myocardial velocities of left ventricular long-axis contraction identify both systolic and diastolic heart failure-a comparison with brain natriuretic peptide, Eur J Heart Fail, 7, 512, 10.1016\u002Fj.ejheart.2004.07.014\nMorimoto, 1997, Effect of exercise on plasma adrenomedullin and natriuretic peptide levels in myocardial infarction, Clin Exp Pharmacol Physiol, 24, 315, 10.1111\u002Fj.1440-1681.1997.tb01194.x",{"VOID":967},"10.1016\u002Fj.hfc.2007.10.003","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1551713607001365",[970,985],{"id":971,"sortIndex":24,"researcher":23,"roles":972,"affiliations":973,"properties":982},"462cda6f-a9de-413a-81d1-127302c31855",[128],[974],{"id":975,"sortIndex":24,"affiliation":976,"properties":23},"18b36b5e-bc7c-4080-8020-9ad450d42965",{"id":975,"createTime":23,"updateTime":23,"relativeEntities":977,"slug":23,"properties":978,"entityType":23,"verifyStatus":23,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":23,"url":23,"parentIds":981,"statistic":23},[],{"title":979},{"VI":980},"University of Queensland, Brisbane, Australia",[],{"title":983},{"VI":984},"Manish Bansal",{"id":986,"sortIndex":143,"researcher":23,"roles":987,"affiliations":988,"properties":995},"f7e37283-ced6-4c7c-9318-f00bee357641",[128],[989],{"id":975,"sortIndex":24,"affiliation":990,"properties":23},{"id":975,"createTime":23,"updateTime":23,"relativeEntities":991,"slug":23,"properties":992,"entityType":23,"verifyStatus":23,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":23,"url":23,"parentIds":994,"statistic":23},[],{"title":993},{"VI":980},[],{"title":996},{"VI":997},"Thomas H. Marwick",{"url":968,"publisher":999,"properties":1046},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":1000,"slug":10,"properties":1001,"entityType":21,"verifyStatus":22,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":24,"subjectFields":1006,"manageAffiliations":1015,"indexDatabases":1026,"url":89,"thumbnailPath":23,"statistic":1041,"gsStatistic":23,"type":23,"analyzePriority":23},[],{"country":1002,"eissn":1003,"issn":1004,"title":1005},{"VOID":13},{"VOID":15},{"VOID":15},{"EN":18},[1007,1011],{"id":27,"createTime":23,"updateTime":23,"relativeEntities":1008,"label":1009,"description":1010,"parentId":23,"standard":23,"scholarHubFieldId":23},[],{"EN":30},{},{"id":33,"createTime":23,"updateTime":23,"relativeEntities":1012,"label":1013,"description":1014,"parentId":23,"standard":23,"scholarHubFieldId":23},[],{"EN":36},{},[1016,1021],{"id":40,"createTime":23,"updateTime":23,"relativeEntities":1017,"slug":23,"properties":1018,"entityType":23,"verifyStatus":23,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":23,"url":23,"parentIds":1020,"statistic":23},[],{"title":1019},{"EN":44},[],{"id":47,"createTime":23,"updateTime":23,"relativeEntities":1022,"slug":23,"properties":1023,"entityType":23,"verifyStatus":23,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":23,"url":23,"parentIds":1025,"statistic":23},[],{"title":1024},{"EN":51},[],[1027,1034],{"id":55,"indexDatabase":1028,"url":66,"indexYears":67,"academicFieldIds":1033,"indexDatabaseRanking":71},{"id":57,"createTime":23,"updateTime":23,"relativeEntities":1029,"label":1030,"description":1031,"key":63,"publicationTags":1032,"standard":23},[],{"EN":60,"VI":60},{"EN":60,"VI":62},[65],[69,70],{"id":73,"indexDatabase":1035,"url":86,"indexYears":23,"academicFieldIds":1040,"indexDatabaseRanking":23},{"id":75,"createTime":23,"updateTime":23,"relativeEntities":1036,"label":1037,"description":1038,"key":82,"publicationTags":1039,"standard":23},[],{"EN":78,"VI":78},{"EN":80,"VI":81},[84,85],[88],{"impactFactor":24,"impactFactorByYear":1042,"i10Index":24,"i10IndexLast5Year":24,"totalPublication":92,"totalPublicationByYear":1043,"totalCitation":24,"totalCitationByYear":1044,"totalCitationPerPublication":24,"totalCitationPerPublicationByYear":1045,"hindexLast5Year":24,"hindex":24},{},{"2007":94,"2008":95,"2009":96,"2011":97},{},{},{"pages":1047,"volume":1049},{"VOID":1048},"71-86",{"VOID":1050},"4","2008-01-01",2008,[71,84],{"id":1055,"createTime":1056,"updateTime":1057,"relativeEntities":1058,"slug":1059,"properties":1060,"entityType":119,"verifyStatus":120,"verifyTime":1057,"verifyNote":122,"languages":23,"translateLanguages":23,"viewCount":24,"primaryUrl":1067,"fullTextUrl":23,"authors":1068,"publicationType":157,"publisherRelationship":1098,"citationCount":23,"citationInfo":23,"publishDate":1150,"publishYear":212,"citationAnalyzeStatus":22,"lastCitationAnalyze":23,"indexDatabases":1151,"openAccess":23,"references":23,"isForceReanalyzing":215},"4ee8cfc7-63f9-41e7-b002-5fca0cdbddda","2024-01-09T20:40:51.605+00:00","2025-02-18T02:32:28.167+00:00",[],"Nursing-Considerations-for-the-Management-of-Heart-Failure-in-the-Emergency-Department",{"title":1061,"references":1063,"doi":1065},{"EN":1062},"Nursing Considerations for the Management of Heart Failure in the Emergency Department",{"VOID":1064},"American Heart Association, 2005\nFonarow, 2003, The Acute Decompensated Heart Failure National Registery (ADHERE): opportunities to improve care of patients hospitalized with acute decompensated heart failure, Rev Cardiovasc Med, 4, S21\nAghababian, 2002, Acutely decompensated heart failure: opportunities to improve care and outcomes in the Emergency Department, Rev Cardiovasc Med, 3, S3\nEmerman, 2002, Effect of emergency department initiation of vasoactive infusion therapy on heart failure length of stay, Ann Emerg Med, 40, S46\nAdams, 2006, Executive Summary: HFSA 2006 comprehensive heart failure practice guideline, J Card Fail, 12, 10, 10.1016\u002Fj.cardfail.2005.12.001\nWilliams, 2005, The half-life of the “teachable moment” for alcohol misusing patients in the emergency department, Drug Alcohol Depend, 77, 205, 10.1016\u002Fj.drugalcdep.2004.07.011\nDominique, 2000, Acute cortisol administration impairs retrieval of long term declarative memory in humans, Nat Neurosci, 3, 313, 10.1038\u002F73873\nDunbar, 2005, Family education and support interventions in heart failure, Nurs Res, 54, 158, 10.1097\u002F00006199-200505000-00003\nLevanthal, 2005, Negotiating compliance in heart failure: remaining issues and questions, Eur J Cardiovasc Nurs, 4, 298, 10.1016\u002Fj.ejcnurse.2005.04.001\nEvangelissta, 2003, Compliance behaviors of elderly patients with advanced heart failure, J Cardiovasc Nurs, 18, 197, 10.1097\u002F00005082-200307000-00005\nCarlson, 2001, Self-care abilities of patients with heart failure, Heart Lung, 30, 351, 10.1067\u002Fmhl.2001.118611\nFrantz, 2004, Breaking down the barriers to heart failure patient self-care, Home Healthc Nurse, 22, 109, 10.1097\u002F00004045-200402000-00012\nReigel, 2002, Facilitators and barriers to heart failure self-care, Patient Educ Couns, 46, 287, 10.1016\u002FS0738-3991(01)00165-3\nJaarsma, 2000, Self-care behavior of patients with heart failure, Scand J Caring Sci, 14, 112, 10.1080\u002F02839310050162343\nDao, 2001, Sensitivity, specificity and accuracy of signs and symptoms in heart failure, J Am Coll Cardiol, 37, 379, 10.1016\u002FS0735-1097(00)01156-6",{"VOID":1066},"10.1016\u002Fj.hfc.2008.08.007","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1551713608001347",[1069,1084],{"id":1070,"sortIndex":24,"researcher":23,"roles":1071,"affiliations":1072,"properties":1081},"198c898f-1065-4964-a396-a7f7364eab0e",[128],[1073],{"id":1074,"sortIndex":24,"affiliation":1075,"properties":23},"8766ba57-d16b-49b5-8025-2c7013b16fe9",{"id":1074,"createTime":23,"updateTime":23,"relativeEntities":1076,"slug":23,"properties":1077,"entityType":23,"verifyStatus":23,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":23,"url":23,"parentIds":1080,"statistic":23},[],{"title":1078},{"VI":1079},"Ephraim McDowell Regional Medical Center, Danville, KY, USA",[],{"title":1082},{"VI":1083},"Elsie M. Selby",{"id":1085,"sortIndex":143,"researcher":23,"roles":1086,"affiliations":1087,"properties":1096},"2a875e70-8369-4a92-a114-b2be57c92537",[128],[1088],{"id":1089,"sortIndex":24,"affiliation":1090,"properties":23},"1fe16bed-53b1-436c-baf5-eb4097175cfe",{"id":1089,"createTime":23,"updateTime":23,"relativeEntities":1091,"slug":23,"properties":1092,"entityType":23,"verifyStatus":23,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":23,"url":23,"parentIds":1095,"statistic":23},[],{"title":1093},{"VI":1094},"Comprehensive CV Consulting LLC, Columbus, OH, USA",[],{"title":1097},{"VI":156},{"url":1067,"publisher":1099,"properties":1146},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":1100,"slug":10,"properties":1101,"entityType":21,"verifyStatus":22,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":24,"subjectFields":1106,"manageAffiliations":1115,"indexDatabases":1126,"url":89,"thumbnailPath":23,"statistic":1141,"gsStatistic":23,"type":23,"analyzePriority":23},[],{"country":1102,"eissn":1103,"issn":1104,"title":1105},{"VOID":13},{"VOID":15},{"VOID":15},{"EN":18},[1107,1111],{"id":27,"createTime":23,"updateTime":23,"relativeEntities":1108,"label":1109,"description":1110,"parentId":23,"standard":23,"scholarHubFieldId":23},[],{"EN":30},{},{"id":33,"createTime":23,"updateTime":23,"relativeEntities":1112,"label":1113,"description":1114,"parentId":23,"standard":23,"scholarHubFieldId":23},[],{"EN":36},{},[1116,1121],{"id":40,"createTime":23,"updateTime":23,"relativeEntities":1117,"slug":23,"properties":1118,"entityType":23,"verifyStatus":23,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":23,"url":23,"parentIds":1120,"statistic":23},[],{"title":1119},{"EN":44},[],{"id":47,"createTime":23,"updateTime":23,"relativeEntities":1122,"slug":23,"properties":1123,"entityType":23,"verifyStatus":23,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":23,"url":23,"parentIds":1125,"statistic":23},[],{"title":1124},{"EN":51},[],[1127,1134],{"id":55,"indexDatabase":1128,"url":66,"indexYears":67,"academicFieldIds":1133,"indexDatabaseRanking":71},{"id":57,"createTime":23,"updateTime":23,"relativeEntities":1129,"label":1130,"description":1131,"key":63,"publicationTags":1132,"standard":23},[],{"EN":60,"VI":60},{"EN":60,"VI":62},[65],[69,70],{"id":73,"indexDatabase":1135,"url":86,"indexYears":23,"academicFieldIds":1140,"indexDatabaseRanking":23},{"id":75,"createTime":23,"updateTime":23,"relativeEntities":1136,"label":1137,"description":1138,"key":82,"publicationTags":1139,"standard":23},[],{"EN":78,"VI":78},{"EN":80,"VI":81},[84,85],[88],{"impactFactor":24,"impactFactorByYear":1142,"i10Index":24,"i10IndexLast5Year":24,"totalPublication":92,"totalPublicationByYear":1143,"totalCitation":24,"totalCitationByYear":1144,"totalCitationPerPublication":24,"totalCitationPerPublicationByYear":1145,"hindexLast5Year":24,"hindex":24},{},{"2007":94,"2008":95,"2009":96,"2011":97},{},{},{"pages":1147,"volume":1149},{"VOID":1148},"125-128",{"VOID":210},"2009-01-01",[71,84],{"id":1153,"createTime":1154,"updateTime":1155,"relativeEntities":1156,"slug":1157,"properties":1158,"entityType":119,"verifyStatus":22,"verifyTime":1155,"verifyNote":1163,"languages":23,"translateLanguages":23,"viewCount":24,"primaryUrl":1164,"fullTextUrl":23,"authors":1165,"publicationType":157,"publisherRelationship":1166,"citationCount":23,"citationInfo":23,"publishDate":1051,"publishYear":1052,"citationAnalyzeStatus":22,"lastCitationAnalyze":23,"indexDatabases":1220,"openAccess":23,"references":23,"isForceReanalyzing":215},"e7a6160f-2de3-4724-afc6-ba5abd98bf2b","2024-01-27T23:27:59.643+00:00","2025-02-17T21:37:02.093+00:00",[],"Left-Ventricular-Filling",{"title":1159,"doi":1161},{"EN":1160},"Left Ventricular Filling",{"VOID":1162},"10.1016\u002Fj.hfc.2007.10.005","Author title is blank","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1551713607001389",[],{"url":1164,"publisher":1167,"properties":1214},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":1168,"slug":10,"properties":1169,"entityType":21,"verifyStatus":22,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":24,"subjectFields":1174,"manageAffiliations":1183,"indexDatabases":1194,"url":89,"thumbnailPath":23,"statistic":1209,"gsStatistic":23,"type":23,"analyzePriority":23},[],{"country":1170,"eissn":1171,"issn":1172,"title":1173},{"VOID":13},{"VOID":15},{"VOID":15},{"EN":18},[1175,1179],{"id":27,"createTime":23,"updateTime":23,"relativeEntities":1176,"label":1177,"description":1178,"parentId":23,"standard":23,"scholarHubFieldId":23},[],{"EN":30},{},{"id":33,"createTime":23,"updateTime":23,"relativeEntities":1180,"label":1181,"description":1182,"parentId":23,"standard":23,"scholarHubFieldId":23},[],{"EN":36},{},[1184,1189],{"id":40,"createTime":23,"updateTime":23,"relativeEntities":1185,"slug":23,"properties":1186,"entityType":23,"verifyStatus":23,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":23,"url":23,"parentIds":1188,"statistic":23},[],{"title":1187},{"EN":44},[],{"id":47,"createTime":23,"updateTime":23,"relativeEntities":1190,"slug":23,"properties":1191,"entityType":23,"verifyStatus":23,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":23,"url":23,"parentIds":1193,"statistic":23},[],{"title":1192},{"EN":51},[],[1195,1202],{"id":55,"indexDatabase":1196,"url":66,"indexYears":67,"academicFieldIds":1201,"indexDatabaseRanking":71},{"id":57,"createTime":23,"updateTime":23,"relativeEntities":1197,"label":1198,"description":1199,"key":63,"publicationTags":1200,"standard":23},[],{"EN":60,"VI":60},{"EN":60,"VI":62},[65],[69,70],{"id":73,"indexDatabase":1203,"url":86,"indexYears":23,"academicFieldIds":1208,"indexDatabaseRanking":23},{"id":75,"createTime":23,"updateTime":23,"relativeEntities":1204,"label":1205,"description":1206,"key":82,"publicationTags":1207,"standard":23},[],{"EN":78,"VI":78},{"EN":80,"VI":81},[84,85],[88],{"impactFactor":24,"impactFactorByYear":1210,"i10Index":24,"i10IndexLast5Year":24,"totalPublication":92,"totalPublicationByYear":1211,"totalCitation":24,"totalCitationByYear":1212,"totalCitationPerPublication":24,"totalCitationPerPublicationByYear":1213,"hindexLast5Year":24,"hindex":24},{},{"2007":94,"2008":95,"2009":96,"2011":97},{},{},{"issue":1215,"pages":1217,"volume":1219},{"VOID":1216},"1",{"VOID":1218},"47-56",{"VOID":1050},[71,84],{"id":1222,"createTime":1223,"updateTime":1224,"relativeEntities":1225,"slug":1226,"properties":1227,"entityType":119,"verifyStatus":120,"verifyTime":1224,"verifyNote":122,"languages":23,"translateLanguages":23,"viewCount":24,"primaryUrl":1234,"fullTextUrl":23,"authors":1235,"publicationType":157,"publisherRelationship":1251,"citationCount":23,"citationInfo":23,"publishDate":1303,"publishYear":320,"citationAnalyzeStatus":22,"lastCitationAnalyze":23,"indexDatabases":1304,"openAccess":23,"references":23,"isForceReanalyzing":215},"bc8bd579-7dc5-46f4-af1a-ab31b0726bd4","2023-12-17T13:32:50.944+00:00","2025-02-16T18:37:54.067+00:00",[],"Lifetime-Circulatory-Support-Must-Not-Be-Restricted-to-Transplant-Centers",{"title":1228,"references":1230,"doi":1232},{"EN":1229},"Lifetime Circulatory Support Must Not Be Restricted to Transplant Centers",{"VOID":1231},"Stewart, 2005, Financial aspects of heart failure programs of care, Eur J Heart Fail, 7, 423, 10.1016\u002Fj.ejheart.2005.01.001\nRedfield, 2002, Heart failure—an epidemic of uncertain proportions, N Engl J Med, 347, 1442, 10.1056\u002FNEJMe020115\nHunt, 2006, Taking heart—cardiac transplantation, past, present and future, N Engl J Med, 355, 231, 10.1056\u002FNEJMp068048\nLee, 2002, Cost analysis of ongoing care of patients with end stage renal disease: the impact of dialysis modality and dialysis access, Am J Kidney Dis, 40, 611, 10.1053\u002Fajkd.2002.34924\nNavia, 2002, Do left ventricular assist device (LVAD) bridge to transplant outcomes predict the results of permanent LVAD implantation, Ann Thorac Surg, 74, 2051, 10.1016\u002FS0003-4975(02)04084-5\nKayala, 2005, Comparison of Novacor and HeartMate vented electric left ventricular assist devices in a single institution, J Heart Lung Transplant, 11, 1973, 10.1016\u002Fj.healun.2005.03.002\nPae, 1992, Ventricular assist devices for postcardiotomy cardiogenic shock. A combined registry experience, J Thorac Cardiovasc Surg, 104, 541, 10.1016\u002FS0022-5223(19)34717-8\nFrazier, 1995, Improved mortality and rehabilitation of transplant candidates treated with a long-term implantable left ventricular assist device, Ann Surg, 222, 327, 10.1097\u002F00000658-199509000-00010\nZhang, 2004, Molecular biology of myocardial recovery, Surg Clin North Am, 84, 223, 10.1016\u002FS0039-6109(03)00222-6\nHetzer, 1999, Cardiac recovery in dilated cardiomyopathy by unloading with a left ventricular assist device, Ann Thorac Surg, 68, 742, 10.1016\u002FS0003-4975(99)00542-1\nSharples, 2006, Evaluation of the left ventricular assist device programme in the United Kingdom, J Heart Lung Transplant, 25, 80, 10.1016\u002Fj.healun.2005.11.113\nRose, 2001, Long-term mechanical left ventricular assistance for end-stage heart failure, N Engl J Med, 345, 1435, 10.1056\u002FNEJMoa012175\nThe United States Renal Data System. 2004 annual data report. Available at: http:\u002F\u002Fwww.usrds.org\u002F. Accessed June 15, 2007.\nWoller, 2005, Clinical applications of stem cells for the heart, Circ Res, 96, 151, 10.1161\u002F01.RES.0000155333.69009.63\nWestaby, 2004, Ventricular assist device as destination therapy, Surg Clin North Am, 84, 91, 10.1016\u002Fj.suc.2003.12.010\nSaito, 2004, Hemodynamics of chronic non-pulsatile flow: implications for development, Surg Clin North Am, 84, 61, 10.1016\u002FS0039-6109(03)00220-2\nWestaby, 2002, Post auricular percutaneous power delivery for permanent mechanical circulatory support, J Thorac Cardiovasc Surg, 123, 977, 10.1067\u002Fmtc.2002.121045\nWestaby, 2006, Six years of continuous circulatory support, N Engl J Med, 355, 325, 10.1056\u002FNEJMc060715\nSiegenthaler, 2006, Mechanical reliability of the Jarvik 2000 Heart, Ann Thorac Surg, 81, 1752, 10.1016\u002Fj.athoracsur.2005.12.013",{"VOID":1233},"10.1016\u002Fj.hfc.2007.05.008","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1551713607000633",[1236],{"id":1237,"sortIndex":24,"researcher":23,"roles":1238,"affiliations":1239,"properties":1248},"92b9d21a-5869-41d4-b580-d4b28f1e8f1d",[128],[1240],{"id":1241,"sortIndex":24,"affiliation":1242,"properties":23},"b34687c4-2b9e-4cc3-adb2-7a844f314207",{"id":1241,"createTime":23,"updateTime":23,"relativeEntities":1243,"slug":23,"properties":1244,"entityType":23,"verifyStatus":23,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":23,"url":23,"parentIds":1247,"statistic":23},[],{"title":1245},{"VI":1246},"Oxford Heart Centre, John Radcliffe Hospital, Oxford, UK",[],{"title":1249},{"VI":1250},"Stephen Westaby",{"url":1234,"publisher":1252,"properties":1299},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":1253,"slug":10,"properties":1254,"entityType":21,"verifyStatus":22,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":24,"subjectFields":1259,"manageAffiliations":1268,"indexDatabases":1279,"url":89,"thumbnailPath":23,"statistic":1294,"gsStatistic":23,"type":23,"analyzePriority":23},[],{"country":1255,"eissn":1256,"issn":1257,"title":1258},{"VOID":13},{"VOID":15},{"VOID":15},{"EN":18},[1260,1264],{"id":27,"createTime":23,"updateTime":23,"relativeEntities":1261,"label":1262,"description":1263,"parentId":23,"standard":23,"scholarHubFieldId":23},[],{"EN":30},{},{"id":33,"createTime":23,"updateTime":23,"relativeEntities":1265,"label":1266,"description":1267,"parentId":23,"standard":23,"scholarHubFieldId":23},[],{"EN":36},{},[1269,1274],{"id":40,"createTime":23,"updateTime":23,"relativeEntities":1270,"slug":23,"properties":1271,"entityType":23,"verifyStatus":23,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":23,"url":23,"parentIds":1273,"statistic":23},[],{"title":1272},{"EN":44},[],{"id":47,"createTime":23,"updateTime":23,"relativeEntities":1275,"slug":23,"properties":1276,"entityType":23,"verifyStatus":23,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":23,"url":23,"parentIds":1278,"statistic":23},[],{"title":1277},{"EN":51},[],[1280,1287],{"id":55,"indexDatabase":1281,"url":66,"indexYears":67,"academicFieldIds":1286,"indexDatabaseRanking":71},{"id":57,"createTime":23,"updateTime":23,"relativeEntities":1282,"label":1283,"description":1284,"key":63,"publicationTags":1285,"standard":23},[],{"EN":60,"VI":60},{"EN":60,"VI":62},[65],[69,70],{"id":73,"indexDatabase":1288,"url":86,"indexYears":23,"academicFieldIds":1293,"indexDatabaseRanking":23},{"id":75,"createTime":23,"updateTime":23,"relativeEntities":1289,"label":1290,"description":1291,"key":82,"publicationTags":1292,"standard":23},[],{"EN":78,"VI":78},{"EN":80,"VI":81},[84,85],[88],{"impactFactor":24,"impactFactorByYear":1295,"i10Index":24,"i10IndexLast5Year":24,"totalPublication":92,"totalPublicationByYear":1296,"totalCitation":24,"totalCitationByYear":1297,"totalCitationPerPublication":24,"totalCitationPerPublicationByYear":1298,"hindexLast5Year":24,"hindex":24},{},{"2007":94,"2008":95,"2009":96,"2011":97},{},{},{"pages":1300,"volume":1302},{"VOID":1301},"369-375",{"VOID":318},"2007-07-01",[71,84],{"id":1306,"createTime":1307,"updateTime":1308,"relativeEntities":1309,"slug":1310,"properties":1311,"entityType":119,"verifyStatus":120,"verifyTime":1308,"verifyNote":122,"languages":23,"translateLanguages":23,"viewCount":24,"primaryUrl":1318,"fullTextUrl":23,"authors":1319,"publicationType":157,"publisherRelationship":1349,"citationCount":23,"citationInfo":23,"publishDate":322,"publishYear":320,"citationAnalyzeStatus":22,"lastCitationAnalyze":23,"indexDatabases":1401,"openAccess":23,"references":23,"isForceReanalyzing":215},"da548e2c-bc6b-4c24-aee5-2c04d1697317","2023-12-07T21:57:16.936+00:00","2025-02-16T08:19:47.217+00:00",[],"DEFEAT-Heart-Failure-Clinical-Manifestations-Diagnostic-Assessment-and-Etiology-of-Geriatric-Heart-Failure",{"title":1312,"references":1314,"doi":1316},{"EN":1313},"DEFEAT Heart Failure: Clinical Manifestations, Diagnostic Assessment, and Etiology of Geriatric Heart Failure",{"VOID":1315},"Aronow, 2006, Epidemiology, pathophysiology, prognosis, an treatment of systolic and diastolic heart failure, Cardiol Rev, 14, 108, 10.1097\u002F01.crd.0000175289.87583.e5\nAronow, 2005, Drug treatment of systolic and of diastolic heart failure in elderly persons, J Gerontol A Biol Sci Med Sci, 60, 1597, 10.1093\u002Fgerona\u002F60.12.1597\nAhmed, 2003, American College of Cardiology\u002FAmerican Heart Association chronic heart failure evaluation and management guidelines: Relevance to the geriatric practice, J Am Geriatr Soc, 51, 123, 10.1034\u002Fj.1601-5215.2002.51020.x\nAhmed, 2004, Diagnosis of heart failure in older adults: predictive value of dyspnea at rest, Arch Gerontol Geriatr, 38, 297, 10.1016\u002Fj.archger.2003.12.001\nHunt, 2005, Circulation, 112, e154, 10.1161\u002FCIRCULATIONAHA.105.167586\nAdams, 2006, Executive Summary: HFSA 2006 comprehensive heart failure practice guideline, J Card Fail, 12, 10, 10.1016\u002Fj.cardfail.2005.12.001\nSwedberg, 2005, Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The task force for the diagnosis and treatment of chronic heart failure of the european society of cardiology, Eur Heart J, 26, 1115, 10.1093\u002Feurheartj\u002Fehi204\nCenters for Medicare & Medicaid Services. Overview of specifications of measures displayed on hospital compare as of December 15, 2005. Available at: http:\u002F\u002Fwww.cms.hhs.gov\u002FHospitalQualityInits\u002F10_HospitalQualityMeasures.asp#TopOfPage. Accessed June 3, 2006.\nJoint Commission on Accreditation of Healthcare Organizations. A comprehensive review of development and testing for national implementation of hospital core measures. Available at: http:\u002F\u002Fwww.jointcommission.org\u002FNR\u002Fexeres\u002F5A8BFA1C-B844-4A9A-86B2-F16DBE0E20C7.htm. Accessed June 3, 2006.\nThe SOLVD Investigators, 1991, Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure, N Engl J Med, 325, 293, 10.1056\u002FNEJM199108013250501\nPfeffer, 1992, Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators, N Engl J Med, 327, 669, 10.1056\u002FNEJM199209033271001\n1997, The effect of digoxin on mortality and morbidity in patients with heart failure, N Engl J Med, 336, 525, 10.1056\u002FNEJM199702203360801\nPacker, 1996, The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. US Carvedilol Heart Failure Study Group, N Engl J Med, 334, 1349, 10.1056\u002FNEJM199605233342101\n1999, Effect of metoprolol CR\u002FXL in chronic heart failure: Metoprolol CR\u002FXL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF), Lancet, 353, 2001, 10.1016\u002FS0140-6736(99)04440-2\nPitt, 1999, The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators, N Engl J Med, 341, 709, 10.1056\u002FNEJM199909023411001\nPitt, 2000, Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial–the Losartan Heart Failure Survival Study ELITE II, Lancet, 355, 1582, 10.1016\u002FS0140-6736(00)02213-3\nHogg, 2004, Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis, J Am Coll Cardiol, 43, 317, 10.1016\u002Fj.jacc.2003.07.046\nVasan, 1999, Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort, J Am Coll Cardiol, 33, 1948, 10.1016\u002FS0735-1097(99)00118-7\nGottdiener, 2002, Outcome of congestive heart failure in elderly persons: influence of left ventricular systolic function. The Cardiovascular Health Study, Ann Intern Med, 137, 631, 10.7326\u002F0003-4819-137-8-200210150-00006\nSenni, 2001, Heart failure with preserved systolic function. A different natural history?, J Am Coll Cardiol, 38, 1277, 10.1016\u002FS0735-1097(01)01567-4\nRedfield, 2003, Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic, JAMA, 289, 194, 10.1001\u002Fjama.289.2.194\nZile, 2001, Heart failure with a normal ejection fraction: is measurement of diastolic function necessary to make the diagnosis of diastolic heart failure?, Circulation, 104, 779, 10.1161\u002Fhc3201.094226\nKitzman, 2002, Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure, JAMA, 288, 2144, 10.1001\u002Fjama.288.17.2144\nAhmed, 2002, Correlates and outcomes of preserved left ventricular systolic function among older adults hospitalized with heart failure, Am Heart J, 144, 365, 10.1067\u002Fmhj.2002.124058\nAhmed, 2003, Clinical correlates of isolated left ventricular diastolic dysfunction among hospitalized older heart failure patients, Am J Geriatr Cardiol, 12, 82, 10.1111\u002Fj.1076-7460.2003.01617.x\nAhmed, 2005, Association of diastolic dysfunction and outcomes in ambulatory older adults with chronic heart failure, J Gerontol A Biol Sci Med Sci, 60, 1339, 10.1093\u002Fgerona\u002F60.10.1339\nRadford, 2005, Circulation, 112, 1888, 10.1161\u002FCIRCULATIONAHA.105.170073\nCheitlin, 2003, Circulation, 108, 1146, 10.1161\u002F01.CIR.0000073597.57414.A9\nZile, 2004, Diastolic heart failure–abnormalities in active relaxation and passive stiffness of the left ventricle, N Engl J Med, 350, 1953, 10.1056\u002FNEJMoa032566\nThomas, 1990, Analysis of the early transmitral Doppler velocity curve: effect of primary physiologic changes and compensatory preload adjustment, J Am Coll Cardiol, 16, 644, 10.1016\u002F0735-1097(90)90356-T\nFleg, 1995, Left ventricular diastolic filling performance in older male athletes, JAMA, 273, 1371, 10.1001\u002Fjama.273.17.1371\nNagueh, 1997, Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures, J Am Coll Cardiol, 30, 1527, 10.1016\u002FS0735-1097(97)00344-6\nSohn, 1997, Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function, J Am Coll Cardiol, 30, 474, 10.1016\u002FS0735-1097(97)88335-0\nThe National Heart Lung, and Blood Institute. Working group on cellular and molecular mechanisms of right heart failure: Executive summary. October 6–7, 2005. Available at: www.nhlbi.nih.gov\u002Fmeetings\u002Fworkshops\u002Fright-heart.htm. Accessed June 3, 2006.\nCosentino, 1999, The congested state in renal failure: A historical and diagnostic perspective, Semin Dial, 12, 307, 10.1046\u002Fj.1525-139X.1999.99016.x\nBraunwald, 1997, Clinical aspects of heart failure: high-output heart failure; pulmonary edema, Volume 1, 445\nWarren, 1944, Fluid dynamics in chronic congestive heart failure, Arch Intern Med, 73, 138, 10.1001\u002Farchinte.1944.00210140028004\nMerrill, 1946, Edema and decreased renal blood flow in patients with chronic congestive heart failure: evidence of “forward failure” as the primary cause of edema, J Clin Invest, 25, 389, 10.1172\u002FJCI101720\nFrancis, 1984, The neurohumoral axis in congestive heart failure, Ann Intern Med, 101, 370, 10.7326\u002F0003-4819-101-3-370\nIngram, 1987, Progressive heart failure secondary to a high output state, Chest, 92, 1117, 10.1378\u002Fchest.92.6.1117\nFroeschl, 2005, Thyrotoxicosis-an uncommon cause of heart failure, Cardiovasc Pathol, 14, 24, 10.1016\u002Fj.carpath.2004.11.003\nAhearn, 1972, Heart failure as a complication of hemodialysis arteriovenous fistula, Ann Intern Med, 77, 201, 10.7326\u002F0003-4819-77-2-201\nGheorghiade, 2005, Acute heart failure syndromes: current state and framework for future research, Circulation, 112, 3958, 10.1161\u002FCIRCULATIONAHA.105.590091\nHaldeman, 1999, Hospitalization of patients with heart failure: National Hospital Discharge Survey, 1985 to 1995, Am Heart J, 137, 352, 10.1053\u002Fhj.1999.v137.95495\nThom, 2006, Heart disease and stroke statistics–2006 update: a report from the American Heart Association statistics committee and stroke statistics subcommittee, Circulation, 113, e85, 10.1161\u002FCIRCULATIONAHA.105.171600\nNieminen, 2005, Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the task force on acute heart failure of the European Society of Cardiology, Eur Heart J, 26, 384, 10.1093\u002Feurheartj\u002Fehi044\nKramer, 2000, Flash pulmonary edema: association with hypertension and reoccurrence despite coronary revascularization, Am Heart J, 140, 451, 10.1067\u002Fmhj.2000.108828\nJong, 2003, Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: a follow-up study, Lancet, 361, 1843, 10.1016\u002FS0140-6736(03)13501-5\nMueller, 2004, Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea, N Engl J Med, 350, 647, 10.1056\u002FNEJMoa031681\nAhmed, 2003, Association of consultation between generalists and cardiologists with quality and outcomes of heart failure care, Am Heart J, 145, 1086, 10.1016\u002FS0002-8703(02)94778-2\nAhmed, 2002, Age-related underutilization of angiotensin-converting enzyme inhibitors in older hospitalized heart failure patients, South Med J, 95, 703, 10.1097\u002F00007611-200207000-00010\nAhmed, 2002, Quality of care of nursing home residents hospitalized with heart failure, J Am Geriatr Soc, 50, 1831, 10.1046\u002Fj.1532-5415.2002.50512.x\nWang, 2005, Does this dyspneic patient in the emergency department have congestive heart failure?, JAMA, 294, 1944, 10.1001\u002Fjama.294.15.1944\nPerloff, 1997, Physical examination of the heart and circulation, Volume 1, 15\nButman, 1993, Bedside cardiovascular examination in patients with severe chronic heart failure: importance of rest or inducible jugular venous distension, J Am Coll Cardiol, 22, 968, 10.1016\u002F0735-1097(93)90405-P\nDrazner, 2001, Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure, N Engl J Med, 345, 574, 10.1056\u002FNEJMoa010641\nCurtis, 2005, The obesity paradox: body mass index and outcomes in patients with heart failure, Arch Intern Med, 165, 55, 10.1001\u002Farchinte.165.1.55\nChatterjee, 2000, Physical examination in heart failure, Volume 1, 615\nDucas, 1983, Validity of the hepatojugular reflux as a clinical test for congestive heart failure, Am J Cardiol, 52, 1299, 10.1016\u002F0002-9149(83)90592-1\nSochowski, 1990, Clinical and hemodynamic assessment of the hepatojugular reflux, Am J Cardiol, 66, 1002, 10.1016\u002F0002-9149(90)90940-3\nYoung, 1977, The swollen leg, Am Fam Physician, 15, 163\nDonaldson, 2000, Chronic Venous Insufficiency, Curr Treat Options Cardiovasc Med, 2, 265, 10.1007\u002Fs11936-000-0021-2\nAronow, 2006, Brain natriuretic peptide in heart failure, J Am Geriatr Soc, 54, 368, 10.1111\u002Fj.1532-5415.2006.00592_2_1.x\nCoats, 1992, Controlled trial of physical training in chronic heart failure. Exercise performance, hemodynamics, ventilation, and autonomic function, Circulation, 85, 2119, 10.1161\u002F01.CIR.85.6.2119\nKo, 2005, The role of exercise training for patients with heart failure, Eura Medicophys, 41, 35\nTenenbaum, 2006, Long-term versus intermediate-term supervised exercise training in advanced heart failure: effects on exercise tolerance and mortality, Int J Cardiol, 113, 364, 10.1016\u002Fj.ijcard.2005.11.098\nCahill, 2006, Progression of preserved systolic function heart failure to systolic dysfunction–a natural history study, Int J Cardiol, 106, 95, 10.1016\u002Fj.ijcard.2004.12.096\nYu, 2002, Progression of systolic abnormalities in patients with “isolated” diastolic heart failure and diastolic dysfunction, Circulation, 105, 1195, 10.1161\u002Fhc1002.105185\nScrutinio, 1994, Prediction of mortality in mild to moderately symptomatic patients with left ventricular dysfunction. The role of the New York Heart Association classification, cardiopulmonary exercise testing, two-dimensional echocardiography and Holter monitoring, Eur Heart J, 15, 1089, 10.1093\u002Foxfordjournals.eurheartj.a060633\nAhmed, 2006, Higher New York Heart Association classes and increased mortality and hospitalization in patients with heart failure and preserved left ventricular function, Am Heart J, 151, 444, 10.1016\u002Fj.ahj.2005.03.066\nAhmed, 2005, Heart failure training: care for older adults with chronic heart failure, J Am Coll Cardiol, 45, 2096, 10.1016\u002Fj.jacc.2005.03.027\nGottdiener, 2000, Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study, J Am Coll Cardiol, 35, 1628, 10.1016\u002FS0735-1097(00)00582-9\nRajappan, 2002, Mechanisms of coronary microcirculatory dysfunction in patients with aortic stenosis and angiographically normal coronary arteries, Circulation, 105, 470, 10.1161\u002Fhc0402.102931\nCecchi, 2003, Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy, N Engl J Med, 349, 1027, 10.1056\u002FNEJMoa025050\nKannel, 2000, Vital epidemiologic clues in heart failure, J Clin Epidemiol, 53, 229, 10.1016\u002FS0895-4356(99)00135-3\nAhmed, 2007, Hospitalizations due to unstable angina pectoris in diastolic and systolic heart failure, Am J Card, 99, 460, 10.1016\u002Fj.amjcard.2006.08.056\nAhmed, 2003, Heart failure mortality among older Medicare beneficiaries: association with left ventricular function evaluation and angiotensin-converting enzyme inhibitor use, South Med J, 96, 124, 10.1097\u002F01.SMJ.0000051271.11872.50\nAhmed, 2002, Use of angiotensin-converting enzyme inhibitors in patients with heart failure and renal insufficiency: how concerned should we be by the rise in serum creatinine?, J Am Geriatr Soc, 50, 1297, 10.1046\u002Fj.1532-5415.2002.50321.x\nAhmed, 2002, Survival benefits of angiotensin-converting enzyme inhibitors in older heart failure patients with perceived contraindications, J Am Geriatr Soc, 50, 1659, 10.1046\u002Fj.1532-5415.2002.50457.x\nAhmed, 2004, Use of beta-blockers in older adults with chronic heart failure, Am J Med Sci, 328, 100, 10.1097\u002F00000441-200408000-00006\nAhmed, 2003, Myocardial beta-1 adrenoceptor down-regulation in aging and heart failure: implications for beta-blocker use in older adults with heart failure, Eur J Heart Fail, 5, 709, 10.1016\u002FS1388-9842(03)00058-8\nAhmed, 2006, Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial, Eur Heart J, 27, 178, 10.1093\u002Feurheartj\u002Fehi687\nYusuf, 2003, Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial, Lancet, 362, 777, 10.1016\u002FS0140-6736(03)14285-7\nAhmed, 2006, Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial, Circulation, 114, 397, 10.1161\u002FCIRCULATIONAHA.106.628347\nAhmed, 2006, Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods, Eur Heart J, 27, 1431, 10.1093\u002Feurheartj\u002Fehi890",{"VOID":1317},"10.1016\u002Fj.hfc.2007.07.005","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS155171360700102X",[1320],{"id":1321,"sortIndex":24,"researcher":23,"roles":1322,"affiliations":1323,"properties":1346},"21b94ef6-8a95-46f8-a103-cb361a74f565",[128],[1324,1335],{"id":1325,"sortIndex":24,"affiliation":1326,"properties":1332},"796dd80f-1fae-4c49-8612-588551aebe05",{"id":1325,"createTime":23,"updateTime":23,"relativeEntities":1327,"slug":23,"properties":1328,"entityType":23,"verifyStatus":23,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":23,"url":23,"parentIds":1331,"statistic":23},[],{"title":1329},{"VI":1330},"University of Alabama at Birmingham, Birmingham, AL, United States",[],{"title":1333},{"VI":1334},"University of Alabama at Birmingham, Birmingham, AL, USA",{"id":1336,"sortIndex":143,"affiliation":1337,"properties":1343},"cd2998e1-74a5-4abb-8888-af3ebc92921d",{"id":1336,"createTime":23,"updateTime":23,"relativeEntities":1338,"slug":23,"properties":1339,"entityType":23,"verifyStatus":23,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":23,"url":23,"parentIds":1342,"statistic":23},[],{"title":1340},{"VI":1341},"Birmingham Veterans Affairs Medical Center, Birmingham, AL, United States",[],{"title":1344},{"VI":1345},"Birmingham Veterans Affairs Medical Center, Birmingham, AL, USA",{"title":1347},{"VI":1348},"Ali Ahmed",{"url":1318,"publisher":1350,"properties":1397},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":1351,"slug":10,"properties":1352,"entityType":21,"verifyStatus":22,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":24,"subjectFields":1357,"manageAffiliations":1366,"indexDatabases":1377,"url":89,"thumbnailPath":23,"statistic":1392,"gsStatistic":23,"type":23,"analyzePriority":23},[],{"country":1353,"eissn":1354,"issn":1355,"title":1356},{"VOID":13},{"VOID":15},{"VOID":15},{"EN":18},[1358,1362],{"id":27,"createTime":23,"updateTime":23,"relativeEntities":1359,"label":1360,"description":1361,"parentId":23,"standard":23,"scholarHubFieldId":23},[],{"EN":30},{},{"id":33,"createTime":23,"updateTime":23,"relativeEntities":1363,"label":1364,"description":1365,"parentId":23,"standard":23,"scholarHubFieldId":23},[],{"EN":36},{},[1367,1372],{"id":40,"createTime":23,"updateTime":23,"relativeEntities":1368,"slug":23,"properties":1369,"entityType":23,"verifyStatus":23,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":23,"url":23,"parentIds":1371,"statistic":23},[],{"title":1370},{"EN":44},[],{"id":47,"createTime":23,"updateTime":23,"relativeEntities":1373,"slug":23,"properties":1374,"entityType":23,"verifyStatus":23,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":23,"url":23,"parentIds":1376,"statistic":23},[],{"title":1375},{"EN":51},[],[1378,1385],{"id":55,"indexDatabase":1379,"url":66,"indexYears":67,"academicFieldIds":1384,"indexDatabaseRanking":71},{"id":57,"createTime":23,"updateTime":23,"relativeEntities":1380,"label":1381,"description":1382,"key":63,"publicationTags":1383,"standard":23},[],{"EN":60,"VI":60},{"EN":60,"VI":62},[65],[69,70],{"id":73,"indexDatabase":1386,"url":86,"indexYears":23,"academicFieldIds":1391,"indexDatabaseRanking":23},{"id":75,"createTime":23,"updateTime":23,"relativeEntities":1387,"label":1388,"description":1389,"key":82,"publicationTags":1390,"standard":23},[],{"EN":78,"VI":78},{"EN":80,"VI":81},[84,85],[88],{"impactFactor":24,"impactFactorByYear":1393,"i10Index":24,"i10IndexLast5Year":24,"totalPublication":92,"totalPublicationByYear":1394,"totalCitation":24,"totalCitationByYear":1395,"totalCitationPerPublication":24,"totalCitationPerPublicationByYear":1396,"hindexLast5Year":24,"hindex":24},{},{"2007":94,"2008":95,"2009":96,"2011":97},{},{},{"pages":1398,"volume":1400},{"VOID":1399},"389-402",{"VOID":318},[71,84],{"id":1403,"createTime":1404,"updateTime":1405,"relativeEntities":1406,"slug":1407,"properties":1408,"entityType":119,"verifyStatus":120,"verifyTime":1415,"verifyNote":122,"languages":23,"translateLanguages":23,"viewCount":24,"primaryUrl":1416,"fullTextUrl":23,"authors":1417,"publicationType":157,"publisherRelationship":1435,"citationCount":23,"citationInfo":23,"publishDate":1150,"publishYear":212,"citationAnalyzeStatus":22,"lastCitationAnalyze":23,"indexDatabases":1487,"openAccess":23,"references":23,"isForceReanalyzing":215},"6e62899f-d7a2-475c-ae8f-b5e81962a27e","2024-01-21T13:38:12.518+00:00","2025-02-15T18:33:11.268+00:00",[],"Heart-Failure-and-the-Emergency-Department-Epidemiology-Characteristics-and-Outcomes",{"title":1409,"references":1411,"doi":1413},{"EN":1410},"Heart Failure and the Emergency Department: Epidemiology, Characteristics, and Outcomes",{"VOID":1412},"Hunt, 2005, ACC\u002FAHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology\u002FAmerican Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol, 46, e1, 10.1016\u002Fj.jacc.2005.08.022\nNieminen, 2005, The task force on acute heart failure of the European Society of Cardiology. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure, Eur Heart J, 26, 384, 10.1093\u002Feurheartj\u002Fehi044\nFonarow, 2005, Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis, JAMA, 293, 572, 10.1001\u002Fjama.293.5.572\nGheorghiade, 2005, Acute heart failure syndromes: current state and framework for future research, Circulation, 112, 3958, 10.1161\u002FCIRCULATIONAHA.105.590091\nSilvers, 2007, Clinical Policies Subcommittee on Acute Heart Failure Syndromes. Clinical policy: critical issues in the evaluation and management of adult patients presenting to the emergency department with acute heart failure syndromes, Ann Emerg Med, 49, 627, 10.1016\u002Fj.annemergmed.2006.10.024\nMaron, 2006, Circulation, 113, 1807, 10.1161\u002FCIRCULATIONAHA.106.174287\nZile, 2002, New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis and measurements of diastolic function, Circulation, 105, 1387, 10.1161\u002Fhc1102.105289\nCollins, 2008, Beyond pulmonary edema: diagnostic, risk stratification, and treatment challenges of acute heart failure management in the emergency department, Ann Emerg Med, 51, 45, 10.1016\u002Fj.annemergmed.2007.07.007\nRedfield, 2003, Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic, JAMA, 289, 194, 10.1001\u002Fjama.289.2.194\nYancy, 2006, Clinical presentation, management and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function; a report from the ADHERE database, J Am Coll Cardiol, 47, 76, 10.1016\u002Fj.jacc.2005.09.022\nFonarow, 2007, Characteristics, treatments and outcomes of patients with preserved systolic function hospitalized for heart failure: report from the OPTIMIZE-HF registry, J Am Coll Cardiol, 50, 768, 10.1016\u002Fj.jacc.2007.04.064\nRosamond, 2008, Heart disease and stroke statistics 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Committee, Circulation, 117, e25, 10.1161\u002FCIRCULATIONAHA.107.187998\nO'Connell, 2000, The economic burden of heart failure, Clin Cardiol, 23, 6\nHugli, 2005, US emergency department visits for decompensated HF, 1992–2001, Am J Cardiol, 96, 1537, 10.1016\u002Fj.amjcard.2005.07.064\nLloyd-Jones, 2002, Framingham Heart Study. Lifetime risk for developing congestive heart failure: The Framingham Heart Study, Circulation, 106, 3068, 10.1161\u002F01.CIR.0000039105.49749.6F\nFonarow, 2008, Epidemiology and risk stratification in acute heart failure, Am Heart J, 155, 200, 10.1016\u002Fj.ahj.2006.10.043\nAdams, 2005, Characteristics and outcomes of patients hospitalized for heart failure in the US: rationale, design and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry, Am Heart J, 149, 209, 10.1016\u002Fj.ahj.2004.08.005\nRoguiin, 2000, Long-term prognosis of acute pulmonary edema—an ominous outcome, Eur J Heart Fail, 2, 137, 10.1016\u002FS1388-9842(00)00069-6\nKaiborod, 2006, National trends in outcomes among elderly patients with heart failure, Am J Med, 119, e1\nForger, 2004, Trends in HF incidence and survival in a community-based population, JAMA, 292, 344, 10.1001\u002Fjama.292.3.344\nFonarow, 2007, Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from the Acute Decompensated Heart Failure National Registry (ADHERE), Am Hear J, 153, 1021, 10.1016\u002Fj.ahj.2007.03.012\nDiercks, 2008, Risk stratification in women enrolled in the acute decompensated heart failure national registry emergency module (ADHERE – EM), Acad Emerg Med, 15, 151, 10.1111\u002Fj.1553-2712.2008.00030.x\nGalvao, 2006, Gender differences in in-hospital management and outcomes in patients with decompensated heart failure: analysis from the Acute Decompensated Heart Failure National Registry (ADHERE), J Card Fail, 12, 100, 10.1016\u002Fj.cardfail.2005.09.005\nGustafsson, 2004, Female sex is associated with a better long-term survival in patients hospitalized with congestive heart failure, Eur Heart J, 25, 129, 10.1016\u002Fj.ehj.2003.10.003\nGhali, 2003, Gender differences in advanced heart failure: Insights from the BEST study, J Am Coll Cardiol, 42, 2128, 10.1016\u002Fj.jacc.2003.05.012\nChrist, 2006, Gender specific risk stratification with BNP levels in patients with acute dyspnea, J AM Coll Cardiol, 48, 1808, 10.1016\u002Fj.jacc.2006.07.037\nAlexander, 1999, Congestive heart failure hospitalizations and survival in California: patterns according to race\u002Fethnicity, Am Heart J, 137, 919, 10.1016\u002FS0002-8703(99)70417-5\nYancy, 2000, Heart failure in African Americans: a cardiovascular enigma, J Card Fail, 6, 183, 10.1054\u002Fjcaf.2000.17610\nAlexander, 1995, Hospitalization for congestive heart failure. Explaining racial differences, JAMA, 274, 1037, 10.1001\u002Fjama.274.13.1037\nDaniels, 2006, J Card Fail, 12, 281, 10.1016\u002Fj.cardfail.2006.01.008\nKeyle, 2007, Disparities in the emergency department evaluation of chest pain patients, Acad Emerg Med, 14, 149, 10.1111\u002Fj.1553-2712.2007.tb01759.x\nGheorghiade, 1998, Chronic heart failure in the United States: a manifestation of coronary artery disease, Circulation, 97, 282, 10.1161\u002F01.CIR.97.3.282\nPurek, 2006, Coronary artery disease and outcome in acute congestive heart failure, Heart, 92, 598, 10.1136\u002Fhrt.2005.066464\nLevy, 1996, The progression from hypertension to congestive heart failure, JAMA, 275, 1557, 10.1001\u002Fjama.275.20.1557\nWilhelmsin, 2001, Heart failure in the general population of men: morbidity, risk factors and prognosis, J Intern Med, 249, 253, 10.1046\u002Fj.1365-2796.2001.00801.x\nKostis, 1997, Prevention of heart failure by antihypertensive treatment in older persons with isolated systolic hypertension, JAMA, 278, 212, 10.1001\u002Fjama.278.3.212\nVakili, 2001, Prognostic implications of left ventricular hypertrophy, Am Heart J, 141, 334, 10.1067\u002Fmhj.2001.113218\nGheorghiade, 2006, Systolic blood pressure at admission, clinical characteristics and outcome in patients hospitalized with acute heart failure, JAMA, 296, 2217, 10.1001\u002Fjama.296.18.2217\nHillege, 2006, Renal function as a predictor of outcome in a broad spectrum of patients with heart failure, Circulation, 113, 671, 10.1161\u002FCIRCULATIONAHA.105.580506\nObialo, 2007, Cardiorenal consideration as a risk factor for heart failure, Am J Cardiol, 99, 21D, 10.1016\u002Fj.amjcard.2006.12.016\nLiang, 2008, Acute decompensated heart failure and the cardiorenal syndrome, Crit Care Med, 36, S75, 10.1097\u002F01.CCM.0000296270.41256.5C\nParkish, 2005, Atrial fibrillation in heart failure: high mortality risk even if ventricular function is preserved, Am Heart J, 150, 701, 10.1016\u002Fj.ahj.2004.12.014\nBerry, 2006, The prevalence, nature and importance of hematologic abnormalities in heart failure, Am Heart J, 151, 1313, 10.1016\u002Fj.ahj.2005.07.032\nFonarow, 2007, An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National Registry, Am Heart J, 153, 74, 10.1016\u002Fj.ahj.2006.09.007",{"VOID":1414},"10.1016\u002Fj.hfc.2008.08.001","2025-02-15T18:33:11.267+00:00","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1551713608001244",[1418],{"id":1419,"sortIndex":24,"researcher":23,"roles":1420,"affiliations":1421,"properties":1432},"26fb1ea2-16c6-4137-910f-ce3bcf8164b5",[128],[1422],{"id":1423,"sortIndex":24,"affiliation":1424,"properties":1430},"3a519c81-7e02-4b6c-ae7c-6a8606463e2d",{"id":1423,"createTime":23,"updateTime":23,"relativeEntities":1425,"slug":23,"properties":1426,"entityType":23,"verifyStatus":23,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":23,"url":23,"parentIds":1429,"statistic":23},[],{"title":1427},{"EN":1428},"New York University Langone Medical Center, New York, NY, USA",[],{"title":1431},{"VI":1428},{"title":1433},{"VI":1434},"Gary B. Green",{"url":1416,"publisher":1436,"properties":1483},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":1437,"slug":10,"properties":1438,"entityType":21,"verifyStatus":22,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":24,"subjectFields":1443,"manageAffiliations":1452,"indexDatabases":1463,"url":89,"thumbnailPath":23,"statistic":1478,"gsStatistic":23,"type":23,"analyzePriority":23},[],{"country":1439,"eissn":1440,"issn":1441,"title":1442},{"VOID":13},{"VOID":15},{"VOID":15},{"EN":18},[1444,1448],{"id":27,"createTime":23,"updateTime":23,"relativeEntities":1445,"label":1446,"description":1447,"parentId":23,"standard":23,"scholarHubFieldId":23},[],{"EN":30},{},{"id":33,"createTime":23,"updateTime":23,"relativeEntities":1449,"label":1450,"description":1451,"parentId":23,"standard":23,"scholarHubFieldId":23},[],{"EN":36},{},[1453,1458],{"id":40,"createTime":23,"updateTime":23,"relativeEntities":1454,"slug":23,"properties":1455,"entityType":23,"verifyStatus":23,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":23,"url":23,"parentIds":1457,"statistic":23},[],{"title":1456},{"EN":44},[],{"id":47,"createTime":23,"updateTime":23,"relativeEntities":1459,"slug":23,"properties":1460,"entityType":23,"verifyStatus":23,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":23,"url":23,"parentIds":1462,"statistic":23},[],{"title":1461},{"EN":51},[],[1464,1471],{"id":55,"indexDatabase":1465,"url":66,"indexYears":67,"academicFieldIds":1470,"indexDatabaseRanking":71},{"id":57,"createTime":23,"updateTime":23,"relativeEntities":1466,"label":1467,"description":1468,"key":63,"publicationTags":1469,"standard":23},[],{"EN":60,"VI":60},{"EN":60,"VI":62},[65],[69,70],{"id":73,"indexDatabase":1472,"url":86,"indexYears":23,"academicFieldIds":1477,"indexDatabaseRanking":23},{"id":75,"createTime":23,"updateTime":23,"relativeEntities":1473,"label":1474,"description":1475,"key":82,"publicationTags":1476,"standard":23},[],{"EN":78,"VI":78},{"EN":80,"VI":81},[84,85],[88],{"impactFactor":24,"impactFactorByYear":1479,"i10Index":24,"i10IndexLast5Year":24,"totalPublication":92,"totalPublicationByYear":1480,"totalCitation":24,"totalCitationByYear":1481,"totalCitationPerPublication":24,"totalCitationPerPublicationByYear":1482,"hindexLast5Year":24,"hindex":24},{},{"2007":94,"2008":95,"2009":96,"2011":97},{},{},{"pages":1484,"volume":1486},{"VOID":1485},"1-7",{"VOID":210},[71,84],{"id":1489,"createTime":1490,"updateTime":1491,"relativeEntities":1492,"slug":1493,"properties":1494,"entityType":119,"verifyStatus":120,"verifyTime":1491,"verifyNote":122,"languages":23,"translateLanguages":23,"viewCount":24,"primaryUrl":1501,"fullTextUrl":23,"authors":1502,"publicationType":157,"publisherRelationship":1586,"citationCount":23,"citationInfo":23,"publishDate":1638,"publishYear":320,"citationAnalyzeStatus":22,"lastCitationAnalyze":23,"indexDatabases":1639,"openAccess":23,"references":23,"isForceReanalyzing":215},"663caa5b-b530-4572-acc3-145aef1266a1","2023-12-12T09:39:22.852+00:00","2025-02-12T19:34:50.453+00:00",[],"Biomarkers-After-Heart-Transplantation-Nongenomic",{"title":1495,"references":1497,"doi":1499},{"EN":1496},"Biomarkers After Heart Transplantation: Nongenomic",{"VOID":1498},"Wang, 1996, Inability of serum myocyte death markers to predict acute cardiac allograft rejection, Transplantation, 62, 1938, 10.1097\u002F00007890-199612270-00046\nGash, 1994, Serum myoglobin does not predict cardiac allograft rejection, J Heart Lung Transplant, 13, 451\nUchino, 1994, Assessment of myocardial damage by circulating cardiac myosin light chain I after heart transplantation, J Heart Lung Transplant, 13, 418\nLaguens, 1996, Anti-skeletal muscle glycolipid antibodies in human heart transplantation as markers of acute rejection. Correlation with endomyocardial biopsy, Transplantation, 62, 211, 10.1097\u002F00007890-199607270-00011\nKorff, 2006, Differential diagnosis of elevated troponins, Heart, 92, 987, 10.1136\u002Fhrt.2005.071282\nZimmermann, 1993, Troponin T release after heart transplantation, Br Heart J, 69, 395, 10.1136\u002Fhrt.69.5.395\nHalwachs, 1996, Troponin T as a marker for posttransplantation adaptational problems of the donor heart, J Heart Lung Transplant, 15, 451\nAlexis, 1998, Cardiac troponin T: a noninvasive marker for heart transplant rejection?, J Heart Lung Transplant, 17, 395\nWalpoth, 1998, Assessment of troponin-T for detection of clinical cardiac rejection, Transpl Int, 11, S502, 10.1111\u002Fj.1432-2277.1998.tb01191.x\nLabarrere, 2000, Cardiac-specific troponin I levels and risk of coronary artery disease and graft failure following heart transplantation, JAMA, 284, 457, 10.1001\u002Fjama.284.4.457\nMullen, 2002, Troponin T and I are not reliable markers of cardiac transplant rejection, Eur J Cardiothorac Surg, 22, 233, 10.1016\u002FS1010-7940(02)00293-2\nHsu, 2003, Soluble inflammatory markers in coronary sinus and peripheral blood of heart transplant recipients, Clin Transplant, 17, 331, 10.1034\u002Fj.1399-0012.2003.00045.x\nCarrier, 1994, Cardiac troponin T and creatine kinase MB isoenzyme as biochemical markers of ischemia after heart preservation and transplantation, J Heart Lung Transplant, 13, 696\nBiagioli, 2003, Graft functional recovery and outcome after heart transplant: is troponin I a reliable marker?, Transplant Proc, 35, 1519, 10.1016\u002FS0041-1345(03)00365-8\nMinami, 2003, Creatine kinase and troponin after myocardial preservation using HTK solution (Custoidol) for clinical heart transplantation, J Heart Lung Transplant, 22, 192, 10.1016\u002FS1053-2498(02)00568-5\nRyan, 2003, The initial rate of troponin I release post-reperfusion reflects the effectiveness of myocardial protection during cardiac allograft preservation, Eur J Cardiothorac Surg, 23, 898, 10.1016\u002FS1010-7940(03)00114-3\nUys, 1979, The pathology of human cardiac transplantation: an assessment after 11 years' experience at Groote Schuur Hospital, S Afr Med J, 56, 887\nWinters, 1991, The pathology of heart allograft rejection, Arch Pathol Lab Med, 115, 266\nHossein-Nia, 1993, Troponin T as a non-invasive marker of cardiac allograft rejection, Lancet, 341, 838, 10.1016\u002F0140-6736(93)90621-M\nDengler, 1998, Elevated serum concentrations of cardiac troponin T in acute allograft rejection after human heart transplantation, J Am Coll Cardiol, 32, 405, 10.1016\u002FS0735-1097(98)00257-5\nChance, 2001, Cardiac troponin T and C-reactive protein as markers of acute cardiac allograft rejection, Clin Chim Acta, 312, 31, 10.1016\u002FS0009-8981(01)00590-3\nVazquez-Rodriguez, 1999, Cardiac troponin T is not a marker of biopsy-proven cellular rejection, J Heart Lung Transplant, 18, 172\nForni, 2000, Correlation between troponin I serum level and acute cardiac allograft rejection: a preliminary report, Transplant Proc, 32, 167, 10.1016\u002FS0041-1345(99)00926-4\nMoran, 2000, Non-invasive assessment of rejection in pediatric transplant patients: serologic and echocardiographic prediction of biopsy-proven myocardial rejection, J Heart Lung Transplant, 19, 756, 10.1016\u002FS1053-2498(00)00145-5\nWahlander, 2002, Sustained elevated concentrations of cardiac troponin T during acute allograft rejection after heart transplantation in children, Transplantation, 74, 1130, 10.1097\u002F00007890-200210270-00013\nSiaplaouras, 2003, Cardiac troponin I: a marker of acute heart rejection in infant and child heart recipients?, Pediatr Transplant, 7, 43, 10.1034\u002Fj.1399-3046.2003.02049.x\nGleissner, 2003, Diagnostic efficiency of rejection monitoring after heart transplantation with cardiac troponin T is improved in specific patient subgroups, Clin Transplant, 17, 284, 10.1034\u002Fj.1399-0012.2003.00050.x\nGleissner, 2002, Extended experience and subgroup analysis using cardiac troponin T for rejection monitoring after heart transplantation, Transplant Proc, 34, 2178, 10.1016\u002FS0041-1345(02)03194-9\nFaulk, 1998, Serum cardiac troponin-T concentrations predict development of coronary artery disease in heart transplant patients, Transplantation, 66, 1335, 10.1097\u002F00007890-199811270-00013\nHokl, 2001, Serum troponin T in the early posttransplant period and long-term graft function in heart recipients, Transplant Proc, 33, 2018, 10.1016\u002FS0041-1345(00)02773-1\nDengler, 1995, Endothelin plasma levels in acute graft rejection after heart transplantation, J Heart Lung Transplant, 14, 1057\nSchmoeckel, 1995, Enhanced endothelin-1 urine excretion in patients with graft arteriosclerosis after heart transplantation, Transplant Proc, 27, 2097\nWexberg, 2002, Intimal hyperplasia and coronary flow reserve after heart transplantation: association with big endothelin-1, J Heart Lung Transplant, 21, 1257, 10.1016\u002FS1053-2498(02)00464-3\nMurthy, 1999, Identification of the G protein-activating domain of the natriuretic peptide clearance receptor (NPR-C), J Biol Chem, 274, 17587, 10.1074\u002Fjbc.274.25.17587\nKenny, 1993, Hydrolysis of human and pig brain natriuretic peptides, urodilatin, C-type natriuretic peptide and some C-receptor ligands by endopeptidase-24.11, Biochem J, 291, 83, 10.1042\u002Fbj2910083\nMcGrath, 2005, The endocrine function of the heart, Trends Endocrinol Metab, 16, 469, 10.1016\u002Fj.tem.2005.10.007\nWahl, 2004, Elimination of the cardiac natriuretic peptides B-type natriuretic peptide (BNP) and N-terminal proBNP by hemodialysis, Clin Chem, 50, 1071, 10.1373\u002Fclinchem.2003.030692\nAtionu, 1993, Cardiac transplantation affects ventricular expression of brain natriuretic peptide, Cardiovasc Res, 27, 188, 10.1093\u002Fcvr\u002F27.2.188\nOgawa, 1996, Evidence for load-dependent and load-independent determinants of cardiac natriuretic peptide production, Circulation, 93, 2059, 10.1161\u002F01.CIR.93.11.2059\nHervas, 2004, Ventricular natriuretic peptide (BNP) in heart transplantation: BNP correlation with endomyocardial biopsy, laboratory and hemodynamic measures, Lab Invest, 84, 138, 10.1038\u002Flabinvest.3700011\nO'Neill, 2005, Brain natriuretic peptide levels do not correlate with acute cellular rejection in De Novo orthotopic heart transplant recipients, J Heart Lung Transplant, 24, 416, 10.1016\u002Fj.healun.2003.12.006\nPark, 2002, Usefulness of B-type natriuretic peptide levels in predicting hemodynamic perturbations after heart transplantation despite preserved left ventricular systolic function, Am J Cardiol, 90, 1326, 10.1016\u002FS0002-9149(02)02871-0\nGeny, 1998, Enhanced brain natriuretic peptide response to peak exercise in heart transplant recipients, J Appl Physiol, 85, 2270, 10.1152\u002Fjappl.1998.85.6.2270\nEl Gamel, 1997, Significance of raised natriuretic peptides after bicaval and standard cardiac transplantation, Ann Thorac Surg, 63, 1095, 10.1016\u002FS0003-4975(97)00168-9\nMehra, 2004, Ventricular-vascular uncoupling increases expression of B-type natriuretic peptide in heart transplantation, Transplant Proc, 36, 3149, 10.1016\u002Fj.transproceed.2004.10.073\nFeldman, 2004, Human B-natriuretic peptide improves hemodynamics and renal function in heart transplant patients immediately after surgery, J Card Fail, 10, 292, 10.1016\u002Fj.cardfail.2003.12.004\nMa, 2004, Selective upregulation of cardiac brain natriuretic peptide at the transcriptional and translational levels by pro-inflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase, J Mol Cell Cardiol, 36, 505, 10.1016\u002Fj.yjmcc.2004.01.001\nMasters, 1999, Discoordinate modulation of natriuretic peptides during acute cardiac allograft rejection in humans, Circulation, 100, 287, 10.1161\u002F01.CIR.100.3.287\nOgawa, 2005, Neuroendocrine profiling of humans receiving cardiac allografts, J Heart Lung Transplant, 24, 1046, 10.1016\u002Fj.healun.2004.06.023\nWu, 2005, Brain natriuretic peptide predicts serious cardiac allograft rejection independent of hemodynamic measurements, J Heart Lung Transplant, 24, 52, 10.1016\u002Fj.healun.2003.10.012\nMehra, 2006, Gene expression profiles and B-type natriuretic peptide elevation in heart transplantation: more than a hemodynamic marker, Circulation, 114, I21\nAmbrosi, 2003, Aminoterminal pro-brain natriuretic peptide and ventricular filling pressures in heart transplant recipients, J Heart Lung Transplant, 22, 822, 10.1016\u002FS1053-2498(02)01158-0\nMehra, 2004, Usefulness of an elevated B-type natriuretic peptide to predict allograft failure, cardiac allograft vasculopathy, and survival after heart transplantation, Am J Cardiol, 94, 454, 10.1016\u002Fj.amjcard.2004.04.060\nKlingenberg, 2005, Determinants of B-type natriuretic peptide plasma levels in the chronic phase after heart transplantation, Transpl Int, 18, 169, 10.1111\u002Fj.1432-2277.2004.00010.x\nAmbrosi, 2004, Usefulness of N-terminal-pro-brain natriuretic peptide levels in predicting survival in heart transplant recipients, Am J Cardiol, 94, 1585, 10.1016\u002Fj.amjcard.2004.08.049\nKirchhoff, 2004, Vasoactive peptides during long-term follow-up of patients after cardiac transplantation, J Heart Lung Transplant, 23, 284, 10.1016\u002FS1053-2498(03)00190-6\nCuppoletti, 2005, Value of NT-proBNP determinations in the follow-up of heart transplantation, Transplant Proc, 37, 4033, 10.1016\u002Fj.transproceed.2005.09.150\nGeny, 1998, Transient reduction without normalization of brain natriuretic peptide early after heart transplantation, J Thorac Cardiovasc Surg, 115, 473, 10.1016\u002FS0022-5223(98)70297-1\nHammerer-Lercher, 2005, B-type natriuretic peptide as a marker of allograft rejection after heart transplantation, J Heart Lung Transplant, 24, 1444, 10.1016\u002Fj.healun.2004.08.018\nGardner, 2006, N-terminal brain natriuretic peptide is predictive of death after cardiac transplantation, Heart, 92, 121, 10.1136\u002Fhrt.2004.057778\nTaylor, 2003, The registry of the International Society for Heart and Lung Transplantation: twentieth official adult heart transplant report–2003, J Heart Lung Transplant, 22, 616, 10.1016\u002FS1053-2498(03)00186-4\nDe Maria, 1989, Nonspecific increase of interleukin-2 receptor serum levels during immune events in heart transplantation, Transplant Proc, 21, 440\nYoung, 1991, Inability of isolated soluble interleukin-2 receptor levels to predict biopsy rejection scores after heart transplantation, Transplantation, 51, 636, 10.1097\u002F00007890-199103000-00018\nJordan, 1993, Serum cytokine levels in heart allograft recipients: correlation with findings on endomyocardial biopsy, J Heart Lung Transplant, 12, 333\nGrant, 1996, Serum cytokines in human heart transplant recipients. Is there a relationship to rejection?, Transplantation, 62, 480, 10.1097\u002F00007890-199608270-00010\nAbdallah, 1997, Evaluation of plasma levels of tumour necrosis factor alpha and interleukin-6 as rejection markers in a cohort of 142 heart-grafted patients followed by endomyocardial biopsy, Eur Heart J, 18, 1024, 10.1093\u002Foxfordjournals.eurheartj.a015361\nLeeuwenberg, 1995, Soluble tumor necrosis factor-receptors are not a useful marker of acute allograft rejection: a study in patients with renal or cardiac allografts, Transpl Int, 8, 459, 10.1111\u002Fj.1432-2277.1995.tb01556.x\nKimball, 1996, The paradox of cytokine monitoring–predictor of immunologic activity as well as immunologic silence following cardiac transplantation, Transplantation, 61, 909, 10.1097\u002F00007890-199603270-00012\nGeorge, 1997, Serial measurements of interleukin-6, interleukin-8, tumor necrosis factor-alpha, and soluble vascular cell adhesion molecule-1 in the peripheral blood plasma of human cardiac allograft recipients, J Heart Lung Transplant, 16, 1046\nFyfe, 1993, Coronary sinus sampling of cytokines after heart transplantation: evidence for macrophage activation and interleukin-4 production within the graft, J Am Coll Cardiol, 21, 171, 10.1016\u002F0735-1097(93)90733-H\nDeng, 1995, The relation of interleukin-6, tumor necrosis factor-alpha, IL-2, and IL-2 receptor levels to cellular rejection, allograft dysfunction, and clinical events early after cardiac transplantation, Transplantation, 60, 1118, 10.1097\u002F00007890-199511270-00011\nWeis, 1998, Soluble interleukin-2-receptor levels as a marker of coronary microvascular dysfunction after heart transplantation, J Heart Lung Transplant, 17, 294\nKao, 2003, Elevated serum levels of the CXCR3 chemokine ITAC are associated with the development of transplant coronary artery disease, Circulation, 107, 1958, 10.1161\u002F01.CIR.0000069270.16498.75\nBeaudeux, 2002, Circulating monocyte chemoattractant protein-1 in heart transplant recipients with cardiac allograft vasculopathy, Clin Biochem, 35, 77, 10.1016\u002FS0009-9120(02)00276-X\nKemkes, 1992, Noninvasive methods of rejection diagnosis after heart transplantation, J Heart Lung Transplant, 11, S221\nStriz, 2001, MRP 8\u002F14 and procalcitonin serum levels in organ transplantations, Ann Transplant, 6, 6\nZavazava, 1996, Soluble HLA class I molecules induce apoptosis in alloreactive cytotoxic T lymphocytes, Nat Med, 2, 1005, 10.1038\u002Fnm0996-1005\nLindaman, 2006, Soluble HLA-G molecules induce apoptosis in natural killer cells, Am J Reprod Immunol, 56, 68, 10.1111\u002Fj.1600-0897.2006.00395.x\nLuque, 2006, Soluble HLA-G in heart transplantation: their relationship to rejection episodes and immunosuppressive therapy, Hum Immunol, 67, 257, 10.1016\u002Fj.humimm.2006.02.034\nZavazava, 1993, Soluble MHC class I antigens (sHLA) and anti-HLA antibodies in heart and kidney allograft recipients, Tissue Antigens, 42, 20, 10.1111\u002Fj.1399-0039.1993.tb02161.x\nRose, 1992, Relation of HLA antibodies and graft atherosclerosis in human cardiac allograft recipients, J Heart Lung Transplant, 11, S120\nLavee, 1991, Influence of panel-reactive antibody and lymphocytotoxic crossmatch on survival after heart transplantation, J Heart Lung Transplant, 10, 921\nKobashigawa, 1996, Pretransplant panel reactive-antibody screens. Are they truly a marker for poor outcome after cardiac transplantation?, Circulation, 94, II294\nThompson, 2000, The influence of conventional and cross-reactive group HLA matching on cardiac transplant outcome: an analysis from the United Network of Organ Sharing Scientific Registry, Transplantation, 69, 2178, 10.1097\u002F00007890-200005270-00038\nJohn, 2000, Impact of current management practices on early and late death in more than 500 consecutive cardiac transplant recipients, Ann Surg, 232, 302, 10.1097\u002F00000658-200009000-00002\nFaulk, 1999, Antibodies to endothelial cells identify myocardial damage and predict development of coronary artery disease in patients with transplanted hearts, Hum Immunol, 60, 826, 10.1016\u002FS0198-8859(99)00056-7\nAzimzadeh, 2005, Humoral immunity to vimentin is associated with cardiac allograft injury in nonhuman primates, Am J Transplant, 5, 2349, 10.1111\u002Fj.1600-6143.2005.01022.x\nOkazaki, 2003, Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice, Nat Med, 9, 1477, 10.1038\u002Fnm955\nSuarez-Alvarez, 2006, The predictive value of soluble major histocompatibility complex class I chain-related molecule A (MICA) levels on heart allograft rejection, Transplantation, 82, 354, 10.1097\u002F01.tp.0000228911.22944.23\nDeng, 1998, T-cell and monocyte subsets, inflammatory molecules, rejection, and hemodynamics early after cardiac transplantation, Transplantation, 65, 1255, 10.1097\u002F00007890-199805150-00018\nBallantyne, 1994, Relationship of increased levels of circulating intercellular adhesion molecule 1 after heart transplantation to rejection: human leukocyte antigen mismatch and survival, J Heart Lung Transplant, 13, 597\nWeigel, 2000, Adhesion molecule behavior during rejection and infection episodes after heart transplantation, Clin Chem Lab Med, 38, 403, 10.1515\u002FCCLM.2000.058\nEisenberg, 2000, Elevated levels of plasma C-reactive protein are associated with decreased graft survival in cardiac transplant recipients, Circulation, 102, 2100, 10.1161\u002F01.CIR.102.17.2100\nPethig, 2000, Systemic inflammatory response in cardiac allograft vasculopathy: high-sensitive C-reactive protein is associated with progressive luminal obstruction, Circulation, 102, III233\nLabarrere, 2001, Pathologic markers of allograft arteriopathy: insight into the pathophysiology of cardiac allograft chronic rejection, Curr Opin Cardiol, 16, 110, 10.1097\u002F00001573-200103000-00006\nHognestad, 2003, Plasma C-reactive protein as a marker of cardiac allograft vasculopathy in heart transplant recipients, J Am Coll Cardiol, 42, 477, 10.1016\u002FS0735-1097(03)00645-4\nHammer, 1998, Procalcitonin: a new marker for diagnosis of acute rejection and bacterial infection in patients after heart and lung transplantation, Transpl Immunol, 6, 235, 10.1016\u002FS0966-3274(98)80013-0\nJaresova, 1999, Serum procalcitonin concentrations in transplant patients with acute rejection and bacterial infections, Immunol Lett, 69, 355, 10.1016\u002FS0165-2478(99)00120-0\nGalatius, 1999, Endothelin and von Willebrand factor as parameters of endothelial function in idiopathic dilated cardiomyopathy: different stimuli for release before and after heart transplantation?, Am Heart J, 137, 549, 10.1016\u002FS0002-8703(99)70505-3\nBirks, 2000, A prospective study of plasma nitrates following human heart transplantation–relevance to myocardial function, J Heart Lung Transplant, 19, 324, 10.1016\u002FS1053-2498(00)00064-4\nSegal, 2001, Coagulation markers predicting cardiac transplant rejection, Transplantation, 72, 233, 10.1097\u002F00007890-200107270-00011\nHolvoet, 2000, Oxidized low density lipoprotein is a prognostic marker of transplant-associated coronary artery disease, Arterioscler Thromb Vasc Biol, 20, 698, 10.1161\u002F01.ATV.20.3.698\nLabarrere, 1994, Tissue plasminogen activator, plasminogen activator inhibitor-1, and fibrin as indexes of clinical course in cardiac allograft recipients. An immunocytochemical study, Circulation, 89, 1599, 10.1161\u002F01.CIR.89.4.1599\nWarshofsky, 1997, Plasma levels of tissue plasminogen activator and plasminogen activator inhibitor-1 are correlated with the presence of transplant coronary artery disease in cardiac transplant recipients, Am J Cardiol, 80, 145, 10.1016\u002FS0002-9149(97)00308-1\nHunt, 1993, Hemostatic changes in heart transplant recipients and their relationship to accelerated coronary sclerosis, Transplantation, 55, 309, 10.1097\u002F00007890-199302000-00016\nMeckel, 1997, Hemostatic\u002Ffibrinolytic predictors of allograft coronary artery disease after cardiac transplantation, Vasc Med, 2, 306, 10.1177\u002F1358863X9700200406\nFiane, 2005, Low mannose-binding lectin and increased complement activation correlate to allograft vasculopathy, ischaemia, and rejection after human heart transplantation, Eur Heart J, 26, 1660, 10.1093\u002Feurheartj\u002Fehi198\nZwirska-Korczala, 2005, Diagnostic validity of hepatocyte growth factor as marker for rejection in the follow-up of patients after heart transplantation, J Heart Lung Transplant, 24, 411, 10.1016\u002Fj.healun.2004.02.007\nNahlawi, 2002, Usefulness of plasma vitamin B(6), B(12), folate, homocysteine, and creatinine in predicting outcomes in heart transplant recipients, Am J Cardiol, 89, 834, 10.1016\u002FS0002-9149(02)02194-X\nDe Chiara, 2005, Blood glutathione as a marker of cardiac allograft vasculopathy in heart transplant recipients, Clin Transplant, 19, 367, 10.1111\u002Fj.1399-0012.2005.00352.x\nZwirska-Korczala, 2006, Serum leptin concentration in patients after heart transplantation, Clin Transplant, 20, 102, 10.1111\u002Fj.1399-0012.2005.00448.x",{"VOID":1500},"10.1016\u002Fj.hfc.2007.02.010","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1551713607000116",[1503,1518,1531,1544,1558,1572],{"id":1504,"sortIndex":24,"researcher":23,"roles":1505,"affiliations":1506,"properties":1515},"e7edec6e-16f6-476d-ac09-8bccf319fcb3",[128],[1507],{"id":1508,"sortIndex":24,"affiliation":1509,"properties":23},"421d8032-22f8-4d60-8157-f4f1ac5d9dc7",{"id":1508,"createTime":23,"updateTime":23,"relativeEntities":1510,"slug":23,"properties":1511,"entityType":23,"verifyStatus":23,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":23,"url":23,"parentIds":1514,"statistic":23},[],{"title":1512},{"VI":1513},"University of Heidelberg, Heidelberg, Germany",[],{"title":1516},{"VI":1517},"Thomas J. Dengler",{"id":1519,"sortIndex":143,"researcher":23,"roles":1520,"affiliations":1521,"properties":1528},"b480bc6f-e2fe-49dc-8ace-a92f3121529b",[128],[1522],{"id":1508,"sortIndex":24,"affiliation":1523,"properties":23},{"id":1508,"createTime":23,"updateTime":23,"relativeEntities":1524,"slug":23,"properties":1525,"entityType":23,"verifyStatus":23,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":23,"url":23,"parentIds":1527,"statistic":23},[],{"title":1526},{"VI":1513},[],{"title":1529},{"VI":1530},"Christian A. Gleissner",{"id":1532,"sortIndex":97,"researcher":23,"roles":1533,"affiliations":1534,"properties":1541},"4e856799-8d8c-4f79-9f46-20e3b759c252",[128],[1535],{"id":1508,"sortIndex":24,"affiliation":1536,"properties":23},{"id":1508,"createTime":23,"updateTime":23,"relativeEntities":1537,"slug":23,"properties":1538,"entityType":23,"verifyStatus":23,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":23,"url":23,"parentIds":1540,"statistic":23},[],{"title":1539},{"VI":1513},[],{"title":1542},{"VI":1543},"Roland Klingenberg",{"id":1545,"sortIndex":1546,"researcher":23,"roles":1547,"affiliations":1548,"properties":1555},"fda3f44d-a1b0-4783-a28a-3f787df16bb2",3,[128],[1549],{"id":1508,"sortIndex":24,"affiliation":1550,"properties":23},{"id":1508,"createTime":23,"updateTime":23,"relativeEntities":1551,"slug":23,"properties":1552,"entityType":23,"verifyStatus":23,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":23,"url":23,"parentIds":1554,"statistic":23},[],{"title":1553},{"VI":1513},[],{"title":1556},{"VI":1557},"Falk-Udo Sack",{"id":1559,"sortIndex":1560,"researcher":23,"roles":1561,"affiliations":1562,"properties":1569},"4e8d47de-e0f8-416f-b840-f3d874fc37ac",4,[128],[1563],{"id":1508,"sortIndex":24,"affiliation":1564,"properties":23},{"id":1508,"createTime":23,"updateTime":23,"relativeEntities":1565,"slug":23,"properties":1566,"entityType":23,"verifyStatus":23,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":23,"url":23,"parentIds":1568,"statistic":23},[],{"title":1567},{"VI":1513},[],{"title":1570},{"VI":1571},"Philipp A. Schnabel",{"id":1573,"sortIndex":1574,"researcher":23,"roles":1575,"affiliations":1576,"properties":1583},"82acc817-4607-44b4-bd3b-c2731186853a",5,[128],[1577],{"id":1508,"sortIndex":24,"affiliation":1578,"properties":23},{"id":1508,"createTime":23,"updateTime":23,"relativeEntities":1579,"slug":23,"properties":1580,"entityType":23,"verifyStatus":23,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":23,"url":23,"parentIds":1582,"statistic":23},[],{"title":1581},{"VI":1513},[],{"title":1584},{"VI":1585},"Hugo A. Katus",{"url":1501,"publisher":1587,"properties":1634},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":1588,"slug":10,"properties":1589,"entityType":21,"verifyStatus":22,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":24,"subjectFields":1594,"manageAffiliations":1603,"indexDatabases":1614,"url":89,"thumbnailPath":23,"statistic":1629,"gsStatistic":23,"type":23,"analyzePriority":23},[],{"country":1590,"eissn":1591,"issn":1592,"title":1593},{"VOID":13},{"VOID":15},{"VOID":15},{"EN":18},[1595,1599],{"id":27,"createTime":23,"updateTime":23,"relativeEntities":1596,"label":1597,"description":1598,"parentId":23,"standard":23,"scholarHubFieldId":23},[],{"EN":30},{},{"id":33,"createTime":23,"updateTime":23,"relativeEntities":1600,"label":1601,"description":1602,"parentId":23,"standard":23,"scholarHubFieldId":23},[],{"EN":36},{},[1604,1609],{"id":40,"createTime":23,"updateTime":23,"relativeEntities":1605,"slug":23,"properties":1606,"entityType":23,"verifyStatus":23,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":23,"url":23,"parentIds":1608,"statistic":23},[],{"title":1607},{"EN":44},[],{"id":47,"createTime":23,"updateTime":23,"relativeEntities":1610,"slug":23,"properties":1611,"entityType":23,"verifyStatus":23,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":23,"url":23,"parentIds":1613,"statistic":23},[],{"title":1612},{"EN":51},[],[1615,1622],{"id":55,"indexDatabase":1616,"url":66,"indexYears":67,"academicFieldIds":1621,"indexDatabaseRanking":71},{"id":57,"createTime":23,"updateTime":23,"relativeEntities":1617,"label":1618,"description":1619,"key":63,"publicationTags":1620,"standard":23},[],{"EN":60,"VI":60},{"EN":60,"VI":62},[65],[69,70],{"id":73,"indexDatabase":1623,"url":86,"indexYears":23,"academicFieldIds":1628,"indexDatabaseRanking":23},{"id":75,"createTime":23,"updateTime":23,"relativeEntities":1624,"label":1625,"description":1626,"key":82,"publicationTags":1627,"standard":23},[],{"EN":78,"VI":78},{"EN":80,"VI":81},[84,85],[88],{"impactFactor":24,"impactFactorByYear":1630,"i10Index":24,"i10IndexLast5Year":24,"totalPublication":92,"totalPublicationByYear":1631,"totalCitation":24,"totalCitationByYear":1632,"totalCitationPerPublication":24,"totalCitationPerPublicationByYear":1633,"hindexLast5Year":24,"hindex":24},{},{"2007":94,"2008":95,"2009":96,"2011":97},{},{},{"pages":1635,"volume":1637},{"VOID":1636},"69-81",{"VOID":318},"2007-01-01",[71,84]]